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ABSTRACT
Impact of Radiation Quality on Esophageal Tissue
by
Latisha T. Pryor
Dr. Janice Pluth, Examination Committee Chair
Professor of Health Physics
University of Nevada, Las Vegas
Radiation-induced esophageal cancer can be a deadly and unfortunate secondary outcome of
radiotherapy or chronic occupational exposure to radiation. Although the esophagus is known to
be a radiosensitive organ, it is under studied and further information regarding how dose and
radiation quality impact its sensitivity may provide strategies to prevent esophageal cancer. The
purpose of this thesis was to understand factors that play a role in the tissue’s radiosensitivity
that may relate to its cancer risk. In this study, we used two esophageal 3D models, as well as
both human and mouse cells, to define radiation quality and dose dependent changes. The study
details radiation-quality and dose dependent changes in: tissue morphology, MAPK/SAPK
phospho-protein expression, crosstalk between the TGFβ and ATM pathways, and DNA damage
kinetics. The results are complex, but provide not only radiation quality and dose dependent
differences, but also species and cell type specific differences in response to radiation. The latter
are especially critical to note when extrapolating results using different model systems. In total,
the results suggest that esophageal tissue is sensitive to high vs. low linear energy transfer (LET)
radiation. In addition, radiation induced changes in phospho-expression may underlie the
changes in tissue morphology and result from alterations in proliferation and/or differentiation.
Lastly, although a definitive answer underlying the rationale for the greater sensitivity of the
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esophagus to radiation was not defined, these studies have provided relevant key findings to
pursue in future studies that should help to resolve this question.
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CHAPTER 1 INTRODUCTION
1.1.

Esophageal Cancer

Esophageal cancer is one of the fastest growing cancers in the United States (Chai and Jamal
2012), ranked the 6th most common globally (Umar 2008), with more than 450,000 people
worldwide diagnosed with esophageal cancer each year since 2008 (Pennathur et al. 2013).
Unfortunately, it is also a very deadly cancer with an overall 5-year survival rate of 15-25% for
patients diagnosed with esophageal cancer (Pennathur et al. 2013). One risk factor for
esophageal cancer is a history of exposure to ionizing radiation.
Higher rates of esophageal cancer have been observed for different radiation-exposed
cohorts, such as Atomic bomb survivors exposed during World War II in Hiroshima and
Nagasaki (Li et al. 2010). Higher rates of esophageal cancer have also been observed in
individuals occupationtionally exposed to radiation, such as nuclear workers throughout the
United States. In a mortality study of 15,727 former Los Alamos National Laboratory employees
exposed to ionizing radiation, an increased risk of esophageal cancer was noted (Wiggs et al.
1994). In a similar study of 45,000 workers from Oak Ridge National Laboratory and Rocky
Flats Nuclear Weapons Plant, individuals chronically exposed to low doses of radiation had an
increased risk of esophageal cancer that was dependent upon the level of radiation exposure
(Gilbert et al. 1989).
Epidemiology studies compiling the outcomes of a number of primary cancers have
shown secondary cancers to be a risk following radiation therapy, with 5% of secondary cancers
thought to be due to radiotherapy, with remaining risk attributed to longer lifespan and genetics
(Dracham et al. 2018). Secondary cancer is defined as cancer that occurs less than 5 years
following radiotherapy treatment, which is located in an organ within the radiation field of the
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previous cancer (Travis et al. 2006). Although radiation oncologists strive to maximize dose to
tumor cells while limiting exposure to normal cells, toxicity to normal tissues is a dose limiting
side effect (Baskar et al. 2012). Organs especially affected are those nearest the radiation target,
such as the esophagus for the breast and lung (Schaapveld et al. 2015). Studies focusing on
esophageal cancer have also noted that previous radiation therapy treatment is associated with an
increase in this secondary cancer (Hall and Wuu 2003, Dracham et al. 2018). The total dose has
also been shown to play a role in the risk of developing secondary esophageal cancer and
estimated to be ~0.3 % per Sievert (Schena et al. 2017).
Radiation exposures treating a number of different diseases have accumulated enough
data to be able to study the risk of secondary esophageal cancer. For example, a large cohort
used to define the risk of secondary esophageal cancer are patients treated for Hodgkin’s
lymphoma. In a study of 19,882 patients treated with radiation for Hodgkin’s lymphoma, a 4.3fold increase risk of radiation induced esophageal cancer was observed. Additionally, another
study revealed a standardized incidence rate of 2.0 for esophageal cancer following radiotherapy
for Hodgkin’s lymphoma (Morton et al. 2014). Secondary esophageal carcinoma risks have also
been shown for patients treated for breast cancer who underwent radiation therapy treatment
(Micke et al. 1999). One study cites a 4.22 increased risk for esophageal adenocarcinomas in
women who were previously treated for breast cancer between the years of 1973-1993 (Lamart et
al. 2013). Additional studies support this increased risk of developing esophageal cancer
following radiotherapy for breast cancer, documenting 252 cases of esophageal cancer in a
cohort of 740 breast cancer patients (Morton et al. 2012).
The dose received during radiotherapy to the primary target has also been shown to play
a role in the risk of developing a secondary cancer. Based on dose reconstruction studies, an
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increased risk was noted in patients who received greater than 30 Gy to the esophagus during
treatment (Morton et al. 2014). An 8.3-fold increase in the development of esophageal cancer
was observed with doses above 35 Gy as compared to women not receiving radiation therapy.
Thus, both prior radiation treatment in the area of the esophagus as well as higher doses to the
target result in an excess risk of developing secondary esophageal cancer. This points to the
importance of improving radiotherapy techniques to limit normal tissue exposure and aid in
reducing the occurrence of secondary carcinomas, which have doubled between the years of
1975-2005 (Dracham et al. 2018).
Conformal types of radiation therapy, which limit more of the dose to the target tissue, is
one way to reduce dose to neighboring tissues and reduce secondary cancer risk. One type of
conformal radiation therapy that has been used more widely is proton beam therapy. For
example, one study (Yock et al. 2016) compared secondary cancers induced by proton therapy in
the treatment of 59 medulloblastoma patients with a previous group that had used photons to
treat this same cancer (Packer et al. 2013), observed no secondary cancers following proton
therapy, but a 2% increase in secondary carcinomas with photon therapy. Additionally, in
another cohort looking at 88 medulloblastoma patients who underwent proton or photon beam
therapy, three children among the 45 photon treated group developed secondary cancers, whereas
none of the 43 patients who received proton therapy did (Eaton et al. 2016). A study by Chung et
al. (Chung et al. 2013) focusing specifically on esophageal secondary cancers, revealed 5.2% of
the patients developed secondary esophageal cancer following proton therapy as compared to
7.5% of the patients treated with photon therapy. Although proton therapy has been associated
with a significantly lowered risk of secondary cancers, the follow up time in these studies was
only ~7 years (Chung et al. 2013, Yock et al. 2016), thus, studies with longer-term follow up will

3

be needed to determine with more certainty whether proton therapy represents a lower overall
risk for radiation induced secondary cancers.
Other conformal radiotherapy treatments that have been used are intensity modulated
radiotherapy (IMRT), conformal three-dimensional radiotherapy (3D CRT), and volumetric arc
therapy (VMAT). In comparing these treatments IMRT has been shown to spare organs outside
of the target area better than 3D CRT (Hall and Wuu 2003, Schena et al. 2017, Filippi et al.
2018) and VMAT delivered dose in a shorter period of time than both CRT and IMRT (Rehman
et al. 2018). Similar to photon therapy total dose is also important in the relative risk for these
more conformal treatments. In a study by Rehman et al., phantoms were used to evaluate the risk
of secondary cancers and to calculate dose to the esophagus for patients treated for head and
neck cancer with either VMAT, IMRT, or 3D CRT (Rehman et al. 2018). The standard dose in
this study was 66 Gy with the maximum dose to the esophagus of ~23 +/-Gy for VMAT, 29 +/Gy for IMRT, and 40+/- Gy for 3D CRT. The probability of normal tissue complication was
defined as 0.4 for VMAT, 0.7 for IMRT, and 4.2 for 3D CRT. In comparing these modalities,
the risk of secondary cancer was lowest for VMAT, with IMRT exhibiting a higher risk and 3D
CRT having the highest risk of all (Rehman et al. 2018). Based on the higher dose predicted
outside the target area for the 3D CRT using the phantom models, these results are likely
expected. However, it should be noted that there is a risk for radiation outside of the target site
for all conformal radiotherapies as well and thus some risk of secondary cancers might still be
expected.
In total these epidemiological studies indicate an association between prior radiation
exposure and cancer development. However, the underlying mechanism for the development of
radiation induced carcinogenesis at a molecular and cellular level is not clearly understood. One
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factor that may play a role in the increased cancer predisposition of the esophagus to radiation is
its increased radiosensitivity, thus a better understanding of this tissues response to radiation may
aid us in defining ways to prevent secondary cancers following prior radiotherapy.
1.2.

The Esophagus and Its Radiosensitivity

To fully understand the effects of radiation on the esophagus it is important to understand its
structure and the cell types that compose this organ. As most people are aware, the esophagus is
a hollow tube within the center of our bodies, ~nine to ten inches in length, connecting the mouth
to the stomach, which functions mainly to propel food to the stomach by peristalsis (Figure. 1)
(Yazaki and Sifrim 2012).

Figure. 1. Location of the esophagus within the body
(WebMD 2019).

At a tissue level, the esophagus can be divided into four distinct layers: mucosa, submucosa,
muscularis propria, and adventitia, moving from the inner to the outer layers. The inner mucosa
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can also be further sub-divided into the stratified squamous epithelium, lamina propria, and
muscalaris mucosae. The squamous epithelium layer protects the outer portion of the organ,
whereas the lamina propria is a thin layer of connective tissue, and the innermost muscularis
mucosa is composed of a thin layer of smooth muscle fibers. The submucosa contains blood and
lymph vessels, which dilate as food passes down the esophagus, and the muscularis propria
contains muscle layers formed by connective fibers that support motor function. Lastly, the
adventitia is a fibrous layer that covers the esophagus and connects it to the stomach (Oezcelik
and DeMeester 2011). A visual image of these layers and their relationship to each other is
shown in Figure 2 for both the human and mouse. The epithelium above the muscularis layer is
the portion of the esophagus made up of flat, thin squamous cells, containing a basal, suprabasal
layer, where most cancers of the esophagus begin. Thus, it is of particular interest to understand
the effect of radiation on these particular esophageal tissue cells. Stem cells also make up a
portion of the epithelial tissue and mutations caused by radiation in this cell type would be
especially dangerous given their multi-potent nature.
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Figure 2. An image of Hematoxylin and Eosin stained
mouse and human esophageal tissue layers (modified
from (Zhang et al. 2017)).

Stem cells are believed to reside within the basal cell layer of the epithelial tissue, but defining
the exact location and markers for esophageal stem cells has been difficult and somewhat
controversial. The current dogma is that a population of actively proliferating cells in the basal
layer work to replenish cell populations in the suprabasal layer of the esophagus tissue (DeNardi
and Riddell 1991). Marques-Pereira and Leblond performed studies using thymidine
incorporation to aid in identifying the location of stem cells and demonstrated that proliferation
occurs in the basal layer of adult rat esophagus, and labeled cells underwent division, and moved
upwards through the epithelium over a 12 h period (Marques-Pereira and Leblond 1965). A more
recent study by Deward et al. (DeWard et al. 2014), using mouse esophageal organoids and cell
lineage tracing, concluded that quiescent stem cells reside within the basal layer. In this latter
study, slowly dividing cells were identified with cell surface marker, Sox2, suggesting a stem
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cell nature for these cells. Further confirmation of their stem cell linage was the fact that Sox2
positive cells had the ability to generate organoids from a single cell. In another study by Doupe
et al., an inducible cre-lox system was used to follow a single cell colony within the esophageal
epithelium in an adult transgenic mouse (Doupe et al. 2012). This cell lineage tracing experiment
helped to further pinpoint and define the esophageal stem cell and its behavior. They observed
that single labeled cell colony would increase in size over time, which led researchers to
speculate that a progenitor population was actively dividing within this basal layer (Doupe et al.
2012). Researchers were able to conclude that the esophageal epithelium contains progenitor
cells that divide approximately twice per week, producing both cycling and differentiated cells in
the process (Doupe et al. 2012). They determined that the stem cell population within the
esophageal epithelium divide, differentiate and flatten as they move upward toward the lumen.
Terminally differentiated cells are then shed within the lumen over time. Rapid cellular turnover
was noted for esophageal epithelial cells, which is perhaps a key factor in the increased
radiosensitivity of the esophagus (Squier and Kremer 2001), as the Law of Bergonié and
Tribondeau (Haber and Rothstein 1969) notes rapid proliferation to be a characteristic of
radiosensitive cells. However, rapid proliferation is likely just one factor involved in this tissue’s
radiosensitivity and other factors may also be at play.
The radiosensitivity of esophagus tissues and cells has been investigated using computed
tomography (CT). Niedzielski et al. used CT to visualize changes in the mean length and volume
of the esophagus (Niedzielski et al. 2017) following radiotherapy. CT imaging of the esophagus
in 134 patients with non small cell lung cancer treated with IMRT was used to predict radiation
toxicity. Esophageal tissue expansion based on voxel-based relative volume changes pointed to
an increase in cellular renewal and thickening of the tissue following radiation exposure. The
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authors concluded that radiation exposure triggered cellular proliferation which in turn increased
the thickness of the esophagus tissue. Thus, it is possible that the increased thickening of the
tissue induced by radiation may be a precursor for changes that in some patients lead to cancer.
Whether all radiation qualities produce similar types of changes and effects to the esophagus is
uncertain, thus it is important to better understand radiation quality differences.

1.3 Radiation Quality and Its Impact on Biological Systems
Typically radiation quality is a term used to describe radiation having differing Linear
energy transfer (LET), or the amount of energy deposited in a material per unit distance (Blakely
1984). Types of radiation with larger LETs also have a higher relative biological effectiveness
(RBE), and thus are more effective in producing biological damage per unit dose (Newhauser
and Durante 2011). Low LET radiation includes such things as X-ray and gamma radiation; and
high LET radiation includes alpha particles and heavy charged particles, like Fe ions. Ionizing
radiation is also known to interact with DNA molecules through both direct and indirect action,
with high LET radiation interacting directly with DNA molecules and low LET producing
damage primarily through indirect mechanisms (Han 2010). Thus, high LET is more effective in
inducing double strand breaks per unit dose as compared to low LET radiation (Han
2010). Therefore, it could likely be speculated that high LET radiation would be more damaging
to esophageal tissue, however it is uncertain whether this greater damage translates to an increase
in cell death or more transformed cells which would provide a greater risk for secondary cancer
risk.
Although both low and high LET radiation produce DNA double strand breaks, high LET
radiation produces more clustered lesions, and shorter DNA fragments as compared to low-LET
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irradiation, which results in more lethal damage (Pang et al. 2011). Using atomic force
microscopy, Pang et al. identified DNA fragments within cells following either high LET Argon
(390 MeV/u) or low LET Co-60 exposure and noted that high LET generated a significantly
larger fraction of short DNA fragments (0-50 nm range). In addition, work has shown that DNA
fragments negatively impact cell survival and repair (Pang et al. 2011). Decreased cell survival
and higher rates of apoptosis following high LET radiation as compared to low LET radiation
was also noted in a study by Niemantsverdriet et al., comparing high LET carbon ions (90
MeV/u) to low LET Cs-137 using irradiated human alveolar basal epithelium cells
(Niemantsverdriet et al. 2012). Thus, at a cellular level high LET has been shown to be more
effective in producing damage and lethal effects, however as mentioned increased levels of
damage and lethal effects may or may not translate to a higher risk of cancer.
Even so, some work has revealed that high LET does have more effectiveness in inducing
cancer, at least in some tissue types. For example Datta et al. used colorectal cancer cells and
compared high LET 56Fe (1000 MeV/u) to low LET Cs-137 radiation, and found high LET
radiation to be more effective in increasing cellular proliferation and reducing differentiation
rates, which promoted tumorigenesis (2013). Forty-six tumors were observed following a 2 Gy
high LET exposure, whereas thirty-six tumors were observed following the low LET exposure,
suggesting a greater effectiveness for tumor-induction with high LET. A possible contributing
reason, and underlying molecular factor, for the higher effectiveness could be that β-catenin is
induced to a greater degree following high LET as compared to low LET gamma radiation (Datta
et al. 2013). β-catenin is an oncogene that plays multifunctional roles within the cell including a
pivotal role in tissue homeostasis, and studies have revealed that aberrantly high expression is
linked to cancer (Newhauser and Durante 2011). Further studies are needed to better understand
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the molecular underpinnings for the greater effectiveness of high LET radiation (Newhauser and
Durante 2011). High LET produces more lethal damage, however low LET produces more nonlethal damages in the DNA which may cause mutations and result in a greater risk of cancer in
subsequent years. In this study, we focus on understanding how radiation quality affects
esophageal cells and esophageal tissues response to radiation. We use various 3D tissue culture
models to more accurately mimic actual esophageal tissue and investigate factors that may be
important in understanding esophageal cells increased risk of radiation-induced carcinogenesis.
Radiation quality effects in the esophagus have not yet been studied to our knowledge,
however studies have been done using a tissue with a similar structure, the skin, and shown
distinct effects depending on the quality of the radiation exposure. Von Neubeck et al.
investigated the effect of high and low LET radiation using three dimensional skin models,
measuring proliferation, differntiation, and repair kinetics (2015). The study quantified the
number of cells within the basal layer and the thickness of each layer within the 3D cultures. The
study showed that low doses of oxygen (500 MeV/n), silicon (400 MeV/n) and iron (600
MeV/n) irradiation, disturbed the cell homeostasis within the 3D structures, promoting
proliferation and differntiation of cells within the tissue. They concluded that radiation quality
rather than dose was the key factor in determining the severity of the biological effect, but
additionally noted that low doses of high LET exposure revealed complex radiation effects
depending on the radiation quality. Further radiation quality differences included an increase in
the basal cell number and thickening of the epidermal layer following O ions, whereas following
Fe ions basal cell numbers were reduced and a more minor change in the epidermal thickness
was noted. Interestingly, another study using a 3D model system, organoids derived from crypt
cells of the small intestine, revealed a decrease in stem cell proliferation following low LET Cs-
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137 irradiation (Martin et al. 2020), again suggesting divergent biological effects by different
radiation qualities. It is unclear what causes the contrary effects between low vs. high LET
radiation, but a clue might be found in understanding differences in the interaction or function of
key pathways, including Transforming Growth Factor Beta (TGFβ) and Ataxia Telangiectasia
Mutated (ATM), at different doses and/or radiation quality exposures.

1.4. Role of TGFβ and ATM Pathways in Radiation Response
Transforming growth factor β (TGFβ) is thought to be important in mediating cellular and tissue
responses to ionizing radiation as well as acting as a tumor suppressor in preventing the
proliferation of a wide variety of cell types (Zhang et al. 2006). Thus, it is a key cytokine
important in maintaining normal tissue homeostasis. Following radiation damage, work has
shown that TGFb signaling is critical in activating the DNA damage response (DDR) (Li et al.
2019). Recent work has shown TGF-b signaling is increased after damage through the
stabilization of TBRII. This stabiliztion of TBRII was dependent upon ATM activation, which
occurs following damage. Thus, these results provide a link between these major pathways and
DNA damage. In support of elevated levels with radiation exposure, a study by Rybkina et al.
revealed occupational workers exposed to chronic gamma ray exposure had elevated TGFβ
levels in their blood as well as increased levels of T-helper cells (2018). In contrast, in cancer
TGFβ acts as a tumor promoter, stimulating cell growth and cell invasion in late stage tumors
(Dancea et al. 2009). In addition, upregulated TGFβ is believed to suppress activation of white
blood cells in the tumor microenvironment preventing immune cells from responding to cancer
cells ((Farhood et al. 2020). As work has shown a link between TGFb and ATM in facilitating
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the repair of DNA damage (Li et al. 2019) it is important to also understand ATM’s role in the
cell.
ATM is a protein kinase that has a multitude of functions within the cell. In normal cells,
ATM maintains genomic stability. Following its activation, ATM protects cells from radiation
damage and promotes cell survival. ATM regulates cell cycle checkpoints after radiation induced
DNA damage, playing an especially important role in S phase. (Kirshner et al. 2006). It also is a
sensor of DNA damage and phosphorylates down-stream proteins critical in responding to
radiation and recruiting repair complexes (Estiar and Mehdipour 2018).
As noted above studies have shown TGFb signaling to be ATM dependent, but other
studies have also shown the importance of TGFb in regulating ATM in response to damage. For
example, Kirshner and team demonstrated in human epithelial cells that TGFβ partially controls
the DNA damage response by regulating ATM activation (2006). In this study, the loss of TGFβ
reduced cellular response to damage and decreased the activity of ATM (Kirshner et al. 2006).
The loss of TGFβ resulted in lower ATM phosphorylation and higher levels of radiation-induced
damage in the epithelial cells (Kirshner et al. 2006). This study points out the reciprocal
regulation of ATM and TGFβ. Other work using A549, adenocarcinomic human alveolar basal
epithelial cells, confirmed TGFβ played a role in stimulating ATM activity, but noted it was not
responsible for the fast activation of ATM and p53 following irradiation (Wiegman et al. 2007).
In summary, this work identifies a connection and reciprocal regulation between the TGFβ and
ATM pathways, but a complete understanding of this relationship and how it may differ
depending on dose or radiation quality is not fully defined. Given the link with DNA damage (Li
et al. 2019), one way to explore the pathways potential interactions is to study the kinetics of the
DNA damage response under various conditions.
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1.5. Ionizing Radiation induced foci as a means to monitor DNA DSB
Following DNA damage, a number of proteins are recruited to the sites of double strand
breaks to aid in its repair. Radiation induced foci, or RIFs, are the name given to the
accumulation of proteins at or near the site of double strand breaks. As many response proteins
are modified by phosphorylation, antibodies against these phosphorylation site have allowed
scientists a way to identify and follow the kinetics of double strand breaks and their repair within
cells (Labay et al. 2011). Studies quantifying radiation induced foci have been around for over
two decades, however a gold standard initially used to study DSB induction and repair is pulsed
field gel electrophoresis (PFGE). In this method cells are radiolabeled, collected after irradiation
and placed into agarose plugs and lysed. Proteins and cellular components are removed in the
lysing process and the agarose containing plugs, placed into a gel and pulse field electrophoresis
is applied to elute the broken fragments of DNA from the plugs into the gel. The amount of DNA
eluted into the gel is thus a measure of the amount of broken DNA. Although this had been the
gold standard for many years, it is very labor intensive and requires higher doses to allow
detection (typically >40 Gy). Thus, when the first study by the Bonner group revealed antibodies
against the phosphorylated form of H2AX would allow detection of DSB within cells at lower
doses (Rogakou et al. 1998), the field rapidly initiated the use of this tool. Numerous subsequent
studies uncovered the number of foci/ cell generally corresponded well with the number of DSBs
in a cells (as identified by other means), although not usually showing equal absolute numbers.
These studies allowed repair kinetics to be defined and modeled down to very low doses
(Rothkamm and Lobrich 2003). However, drawbacks exist as well in scoring foci. Initially many
researchers quantified foci by eye, which was labor intensive and subjective, but computer
software and ensuring that slides are scored blindly have aided in resolving these issues
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(Rothkamm et al. 2015, Barbieri et al. 2019). Nevertheless, an avalanche of subsequent foci
studies has slowly revealed additional caveats that should be understood when attempting to
define DSB levels by this method.
As noted, foci counting is effective in providing estimates of DSBs, however an
individual foci does not necessarily indicate just one DSB. Work has shown that closely spaced
foci may not be able to be resolved under the microscope or merge with those in close proximity
(Barbieri et al. 2019). Costes et al. performed extensive RIF studies describing radiation quality
dependent differences and repair kinetics and revealed different phospho-proteins may have
unique radiation quality dependent kinetics (Costes et al. 2006). Using a low LET and high LET
radiation quality (x-ray and Nitrogen 130 MeV/u respectively), they observed that the size and
frequency of ATM foci were radiation quality dependent, with high LET exposures resulting in
larger foci, that were induced more rapidly as compared with low LET (Costes et al. 2006).
However, gH2AX foci showed similar maximum induction and repair kinetics following high
and low-LET exposures exhibiting maximal levels up to 2 hr post exposure. In the current study,
both a protein that resides within the chromatin, gH2AX, and a protein recruited to the sites of
damages 53BP1 is monitored to define the induction and repair of DSBs, as well as the
persistence of foci many days post exposure to better understand esophageal tissue’s sensitivity
to radiation.
Studies over the past decades using gH2AX and 53BP1 as markers of DSBs have
revealed some similarities and differences. Phosphorylation of H2AX has been the most widely
used modification to define the kinetics of DNA damage and repair. After a DNA double strand
break has been induced, the variant histone, H2AX is phosphorylated on Serine-139 at or near
the site of damage by typically one of three kinases: ataxia-telangiectasia mutated (ATM), ataxia
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telangiectasia mutated and Rad3-related (ATR) or DNA-dependent protein kinase (DNA-PK), to
form the phosphorylated form, gH2AX (Rothkamm et al. 2015). A difficulty in using this DSB
marker to establish the number of DSB is that the variant histone is also modified during S phase
when the chromatin is disturbed. Thus, cells in S phase or early G2 often exhibit an increase in
gH2AX foci/cell. Tu et al., performed elaborate studies using HeLa cells to show that
phosphorylation of H2AX can occur in some cases in the absence of any DNA damage (Tu et al.
2013). Often however, foci in S phase cells look different and have a more of a pan-nuclear
staining, thus another way to focus only on DNA damage foci is to eliminate cells showing a
pan-nuclear sort of staining from the analysis (de Feraudy et al. 2010).
Given differences may exist between RIF kinetics dependent on the modified DNA
response protein studied (Kurashige et al. 2016), it is often useful to monitor a second protein
known to accumulate at DSBs, such as 53BP1. The DNA damage marker, 53BP1, is thought to
be recruited to the site of DNA damage after gH2AX foci formation. 53BP1 (p53 binding protein
1) has been shown to be important in the signaling and repair of double-strand breaks. As the
name suggests, 53BP1 is a protein that binds to p53. It also binds to damaged chromatin and is
known to regulate DNA repair pathway choice (Panier and Boulton 2014). During G1, it
stimulates non-homologous end-joining (NHEJ)-mediated DSB repair by hindering DNA endresection that occurs at a distance, which is needed for homologous recombination repair. The
binding protein also regulates the cell’s response to DNA breaks and promotes repair via NHEJ
(Panier and Boulton 2014). A number of studies suggest that ATM is the primary kinase
activating 53BP1 following damage (Lee et al. 2010) although, another study indicates that
53BP1 is not dependent on ATM for its activation and that DNA PKcs can also activate 53BP1
(Schultz et al. 2000). Similar to gH2AX, 53BP1 foci exhibit a dose-dependent number of
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foci/cell. In addition, exposure of rat thyroid cells to 2Gy irradiation shows that the number of
foci/cell as defined using each marker produce very similar results (Kurashige et al. 2016).
Monitoring both 53BP1 and gH2AX DNA damage markers in esophageal 3D tissue models will
allow us to better understand esophageal tissue sensitivity to radiation and if unique differences
are evident based on dose, radiation quality, or time.

1.6 Different 3-D tissue models useful in studying environmental effects and mimicking in
vivo esophageal exposures
Different 3D model systems have been used to mimic the esophageal tissue. The 3D organotypic
culture (OTC) is structurally and morphologically similar to a section of a normal esophageal
tissue (Whelan et al. 2018). To set up OTC esophageal epithelial cells are seeded over a collagen
matrix containing fibroblasts inside a transwell. The collagen fibroblast layer mimics the
subepithelial lamina propria within the actual esophageal tissue (Figure 3A). Epithelial cells are
layered over the fibroblast/collagen matrix and stimulated to divide by removing medium from
the transwell and providing an air/liquid interface. Thus, OTC include both fibroblast and
epithelial cells allowing insight into how radiation impacts both cell types and the
communication between cells. A drawback of this model is that is does not originate from a
single stem cell as the organoid model does. But this model system has been used extensively to
study effects of growth factors and to model esophageal cancer (Michaylira et al. 2010,
Natsuizaka et al. 2010), as well as various disease states such as Barrett’s esophagus (Yan et al.
1997). Although to date no studies have been done investigating the effects of radiation using
this esophageal 3D model system.
A second less complex three-dimensional model is the esophageal organoid. Compared to
organotypic cultures, organoids are derived from a single cell or a small number of cell clusters

17

containing a stem/progenitor cell (Figure 3B) and grown in Matrigel which serves as a basement
membrane for the structure (Figure 3B). Similar to organotypic culture, organoids can be used to
study cell interactions, proliferation, stress response, and communication mechanisms between
cells within tissues and to obtain data closer to the in vivo situation (Whelan et al. 2018).
Organoids are also less labor intensive to make and less variable, and can be produced in large
numbers, in contrast to OTC. One recent study by Fernandez-Antoran et al. used both transgenic
mouse models and OTC to study the effect of very low doses of cesium (50 mGy) (2019). This
work revealed wild-type cells to be inhibited from proliferating following radiation, whereas p53
mutant cells in the tissue were insensitive to low dose radiation and increased in number. This
selective survival advantage of p53 mutant cells resulted in greater numbers of p53 mutant cells
within the OTC. This study revealed that very low doses (50 mGy) of low LET radiation can
potentially disrupt the normal homeostasis of the tissue, and result in an increase in mutant cells,
which, if not eliminated, could progress to cancer.
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Figure 3. Comparison of esophageal organotypic culture (OTC) and
organoid 3D model systems. The preparation of an OTC is described in
(A). Esophageal epithelial cells and fibroblasts are grown in monocultures prior to being combined in a transwell plate. Fibroblasts are first
layered in a collagen matrix on the bottom of the transwell, followed by
epithelial cells on top. To initiate epithelial proliferation, medium is
removed and the air-liquid interface between the medium and
environment triggers division. The lower image shows an H&E stained
OTC section with the various layers including the basement membrane
and epithelial layers, nicely mimicking actual tissue. (B) Cartoon of how
esophageal spheroid organoids compare to OTC. Matrigel and single
cells are combined and plated to grow into a 3D structure. The bottom
image on the right shows a H&E stained organoid section, revealing its
epithelial layers mirroring the actual esophageal tissue’s epithelial
portion, with the center containing the thin shedding cells which would
be lining the lumen in a real esophagus. (Image modified from (Zhang et
al. 2017)).

Although no studies have been performed using esophageal OTC or organoids to study
radiation quality effects, studies have been done using other tissues in 3D. For example, human
lung epithelial cells show a decreased rate of proliferation, a lower level of DNA damage and
fewer apoptotic cells following either Fe 600 MeV/n or Cs-137 exposure when cells were
cultured in 3D as compared to 2D (El-Ashmawy et al. 2016). Thus, researchers concluded that
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the frequency of radiation induced effects were overestimated in 2D cultures (El-Ashmawy et al.
2016). A similar study looking at radiation-induced damage in lung organotypic cultures,
comparing 2D to 3D tissues, found 3D cultures exhibited less damage at various timepoints
following ionizing radiation. Work by Wu et al. suggested radiation induced bystander effects
were present both in exposed 2D or 3D cell cultures, however foci levels were significantly
higher in 2D cultures following x-rays and carbon ions (Wu 2015). In addition, rectal tumors
from patients have been used to construct patient derived organoids (PDX) and used to predict
response to radiotherapy, as characterized by an increased radiation sensitivity. Of note, the PDX
response to radiation predicted a patients’ response to radiation with 84.43% accuracy (Yao et al.
2020). Thus, in summary 3D studies appear to show lowered levels of foci and accurately reflect
a patient’s response to radiation, thus likely providing a more suitable model as compared to 2D
for modeling radiation response in vivo.

1.7 Scope of Study
The primary objective of this thesis was to examine the radiosensitive properties of the
esophagus following high and low LET radiation. It is hypothesized that: (1) radiation impacts
the structure of esophageal tissues leading to a greater risk of damage with high LET radiation,
(2) TGFβ and ATM pathways are key in the response to radiation, and (3) persistent levels of
DNA damage exists and kinetics of such repair is different among cell types.
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CHAPTER 2

MATERIALS AND METHODS
2.1 Defining Dose and Radiation Quality Effects Using Mouse Esophageal Organoids
Phase contrast images of organoids following radiation (prior to fixation) appeared to show a
thickening in organoid cell layers exposed to the greater dose of high LET radiation. This study
was designed to more robustly quantify changes in the thickness of cell layers using images of
fixed, embedded, sectioned and Hematoxylin & Eosin (H&E) stained organoids. The study
compared dose and radiation quality effects.

Figure 4. Representative H&E stained image of mouse esophageal
organoid image and measurements defined for each organoid. An
example of a typical H&E stained esophageal organoid section (A). A
graphical representation of the various tissue layers measured and
lengths quantified for each organoid (B).

Prior to irradiation at the Brookhaven National Laboratory (BNL), mouse organoids were prepared
by our collaborators (ie., Dr. Rustagi) at the University of Pennsylvania using freshly isolated
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mouse esophageal cells. Cultures were then transported to BNL and irradiated the following day
and further cultured for 9 days prior to fixation. Samples were fixed and sent out to be paraffin
embedded, sectioned, and placed on slides. One section of each sectioned sample was H&E
stained.
Doses: 0, 0.1, and 1 Gy
Radiation quality exposures: Fe600 MeV/n and Cesium
The irradiation, staining and images were all taken previously at Lawrence Berkeley National Lab
(LBNL), and images were analyzed in the current study.
Analysis: ImageJ was used to measure the basal cell layer, whole cell layer (from outer organoid
to inner sloughing cells), length of total organoid, width of total organoid, and length of lumen
(center pink portion) (see Figure 4B).
Analysis criteria for inclusion of organoids for scoring: As organoids are within the matrix at
different heights within the gel, when it is sectioned some will be cut off either near the very top
or bottom of an organoid. and at different stages of development in some cases, therefore a criterion
for exclusion was defined:
1) Organoids sliced in such a way where no lumen or cell layers are observed
2) Organoids where the outermost cell layer does not surround the entire organoid
3) Organoids which are merged together.

2.2. Defining Dose-response of MAPK/SAPK Signaling in Mouse Esophageal Organoids in
Response to Fe 600 MeV/n Exposure
The purpose of this experiment was multi-fold. As esophageal tissue is a radiation-sensitive tissue,
we wanted to have a better understanding of this tissue’s cellular response to a less well-studied
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radiation quality, Fe 600 MeV/u. We chose to center on the MAPK/SAPK stress pathway and
defined expression at 24 hours following exposure using human esophageal organoid samples as
a surrogate for human esophageal tissue. Our first objective was to define the dose-response pattern
of protein expression in the MAPK/SAPK stress pathway following high LET radiation exposure.
Secondly, as TGFb has an important role both in cancer and normal tissue homeostasis, and is
induced with radiation, we wanted to better understand its role in regulating phospho-protein
expression following radiation. In addition, ATM also plays a critical role in responding to
radiation and DNA damage. More recent studies have indicated ATM and TGFb may
cooperatively regulate cellular response to radiation (Wang et al. 2013, Overstreet et al. 2015, Park
et al. 2015). Thus, a third part of this study was to define phospho-proteins which appear to
coordinately regulate, and be perhaps uniquely regulated at low vs. high doses of high LET
radiation. To investigate these latter questions various inhibitors and growth factors were added
including: TGFb, TGFb inhibitor, ATM inhibitor, as well a combination of ATM and TGFb
inhibitors.
Human esophageal (3D) organoid samples were prepared by our collaborators (Dr. Rustagi) at
the University of Pennsylvania.
Doses: 0, 0.1 and 1 Gy
Radiation quality: Fe600 MeV/n
Samples were treated with: ATM Kinase inhibitor (ATMi), Transforming Growth Factor β
(TGFβ), TGFβ inhibitor (TGFβi), or both ATMi and TGFβi, one hour prior to irradiation.
Code names for each treatment group:
Control= Sham irradiated
+ ATMi= samples + ATM inhibitor
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+TGFβ = samples + TGFb
+TGFβi = samples+ TGFβ inhibitor
+ATMi + TGFβi = samples + ATM inhibitor and TGFβ inhibitor
Concentrations of various chemicals used:
ATM inhibitor (KU-55933): 5 µM
TGFβ:1ng/ml (Stock is 1 mg/ml)
TGFβ inhibitor (SD208):1 µM.
Chemical additions were made 1 hr prior to radiation and samples collected 24 hr post exposure.
The Milliplex Map 10plex human MAPK/SAPK Signaling Magnetic Bead Kit (Millipore Sigma,
Burlington, Massachusetts) was used to determine changes in various phospho-proteins in the
MAPK/SAPK pathway (Figure 5). The kit detects expression levels for 10 phosphorylated
proteins in cell lysates: ATF2 (Thr71), JNK (Thr 183/Tyr 185), HSP27 (Ser 78), p38 (Thr
180/Tyr 182), ERK/MAP kinase ½ (Thr 185/ Tyr 187), p53 (Ser 15), MEK1 (Ser 217/221),
MSK1 (Ser 212), STAT1 (Tyr 701), and c-Jun (Ser 73). BW in the Pluth Lab performed the
assay which was run on the Luminex machine (06/2019) at UNLV according to the standard
protocol. Samples were run in duplicate with the exception of the control +TGFb sample and the
ATMi+ TGFβi samples, which due to a low amount of lysate were only run once. The analysis
was performed as part of this work.
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Figure 5. MAPK/SAPK Stress Pathway. The MAPK
family includes stress-activated protein kinases (SAPK)
and Jun amino-terminal kinases (JNK) that are activated
by environmental stressors, including radiation. The
phosphorylated proteins under analysis are: ATF2, JNK,
HSP27, p38, Erk/MAPKinase 1/2, p53, MEK1, MSK1,
STAT-1, and c-Jun, see phospho-sites under methods).
(Image courtesy: 10Plex_MAPK_SAPK product manual).

2.3. A Comparison of SAPK/MAPK Phospho-Protein Response in Human and Mouse
Esophageal Organoids Following Different Radiation Qualities
The objective of this study was to understand the persistent stress response in esophageal tissue
induced by various doses and radiation qualities. As a surrogate for actual esophageal tissue we
utilized 3D esophageal organoid samples. Additionally, as many studies have been performed
using mouse models, we wanted to define if different patterns of response are observed for
human compared to mouse.
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Human esophageal (3D) and mouse esophageal (3D) samples were exposed to 0, 0.1 and 1 Gy
high LET radiation (Fe600 MeV/n) and low LET radiation (Cs) at BNL. Esophageal samples
included in the study are human EPC cell organoids 9 days post Fe600 exposure, mouse cell
organoids 9 days post Fe600 exposure, human EPC cell organoids 9 days post Cs exposure, and
mouse cell organoids 9 days post Cs exposure. Changes in various phosphoprotein expression
were defined using the Milliplex Map 10-plex human MAPK/SAPK Signaling Magnetic Bead Kit
(Millipore Sigma, Burlington, Massachusetts). The assay was performed at UNLV according to
the standard protocol and samples were run in duplicate. The same sham irradiated sample was
used as the control for both radiation qualities. The analysis was set up to define: (1) dose response,
(2) radiation quality differences, and (3) species differences.

2.4. Radiation Quality and Dose-dependent Effects on Persistence of ƔH2AX in Mouse
Esophageal Organoids
Mouse esophageal organoids were treated with Fe600 MeV/n or Cesium to compare radiation
quality effects on the persistence of gH2AX in mouse 3D esophageal organoids. 3D Organoids
were used to mimic in vivo tissues and stained for gH2AX, a marker of double strand breaks
(DSB), nine days following exposure to define persistent effects.

26

Figure 6. Example of esophageal organoid stained for γH2AX foci
following 0.1 Gy Fe600 MeV/n. γH2AX is labeled with Alexa 488
(green) and cell nuclei are counterstained with DAPI (blue).

Esophageal organoids were prepared by our collaborators (Dr. Rustagi) at the University of
Pennsylvania using mouse esophageal cells, basically as previously described (Kalabis et al. 2012).
The organoids were seeded 1 day prior to irradiation and grown for nine days post exposure, or for
10 days total growth, a timepoint when organoids are typically fully formed.
Doses: 0, 0.1, and 1 Gy
Radiation quality: high LET radiation (Fe 600 MeV/n) or low LET radiation (Cesium)
Timepoint: Nine days post exposure (216 hours)
Processing: organoids were fixed in formalin, sent to a core laboratory for paraffin embedding and
sectioned onto slides. Slides were then processed and stained using DNA damage signaling
protein/phosphoproteins γH2AX (1:800) (Figure 6).
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Staining and images were completed

previously at LBNL, and current analysis was performed using images taken from these stained
sections.
ImageJ was used to quantify fluorescent foci within the DAPI stained cells of the organoids.
Slides were scored blindly for total number of foci-positive cells per organoid. A one-way
ANOVA was used to test significance.
Criteria for exclusion of images from scoring analysis:
1) Partial organoids, where it was cut off in the image
2) No clear staining of foci, green Alexa 488 signal was not sufficient to allow detection
3) Unclear staining of cell nucleus. Blue DAPI staining to identify each nucleus was suboptimal.

2.5 Radiation and Dose-dependent Impact on 53BP1 Foci Persistence in Esophageal Mouse
Organoids
This experiment examined differences in radiation quality effects between high (Fe600 MeV/n)
and low LET (Cs) radiation using a three-dimensional (3D) mouse esophageal organoid to best
mimic in vivo effects. Organoids were prepared by our collaborators (Dr. Rustagi) at the
University of Pennsylvania using mouse esophageal cells, basically as previously described
(Kalabis et al. 2012). Organoids were seeded 1 day prior to irradiation and grown for nine days
post exposure, a time point where organoids should typically be fully formed (day 10).
Exposure doses: 0, 0.1 and 1 Gy
Radiation qualities: Fe 600 MeV/n or Cesium irradiated at BNL
Time point: nine days post exposure (216 hours)
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Processing: organoids were fixed in formalin, sent to a core laboratory to be paraffin embedded
and sectioned onto slides. Slides were then processed and stained using a fluorescently taggedantibody against 53BP1, a protein known to accumulate at the sites of double strand breaks
(DSBs). Staining and imaging of the organoids were done at LBNL, but levels of 53BP1 foci
were quantified in the present study.

Figure 7. Representative image of mouse esophageal
organoid exposed to 0.1 Gy Fe600 MeV/n and stained for
53BP1 foci. 53BP1 is labeled with Alexa 488 (green) and cell
nuclei are counterstained with DAPI (blue). The representative
image shows r cells within the organoid that contain foci (within
red circles). This organoid would be scored as having 53BP1
positive foci containing cells.
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Analysis:
ImageJ was used to quantify fluorescent foci within DAPI stained nuclei of cells within the
organoid. For each esophageal organoid the number of foci positive cells was defined.
Figure 7 shows a representative organoid image post a 0.1 Gy dose of Fe 600 MeV/n. Data
obtained from each image include:
1) Total number of organoids
2) Number of 53BP1 foci-positive cells
3) We also recorded the number of pan stained cells within the organoids. Pan stained cells
do not have distinct foci, but instead have an entirely green fluorescent nucleus.

2.6. gH2AX Kinetics in Human Esophageal Organotypic Cultures Following Fe 600 MeV/n
Exposure
Tissue culture studies done in two dimensions (2D), or in a standard mono-culture, may not
accurately reflect what occurs in vivo. Thus, to better understand how radiation may impact cells
and tissues in vivo we used three-dimensional (3D) esophageal organotypic cultures (OTC) to
examine DNA damage response following high LET radiation using the double-strand break
marker gH2AX.
Human organotypic cultures (OTC) were seeded by our collaborators (Dr. Rustagi) at the
University of Pennsylvania using human esophageal cells, transported to BNL for analysis and
irradiated 6 days post set up. Human esophageal epithelial cells (referred to as EPC) and human
esophageal fibroblast cells (referred to as FEF3) were used to seed OTC cultures. At the
appropriate timepoint, cultures were fixed and sent to a core laboratory for paraffin embedding,
sectioning, and placing sections on slides. Slides were then stained for the DNA damage
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signaling protein gH2AX at LBNL and imaged. Analysis and quantification were performed
using these images and are discussed in the present work.

Figure 8. Example of OTC 3D tissue culture
stained with gH2AX 2 hours post 0.1 Gy. gH2AX
foci (green) and ATF2 Ser 490/498 (red) foci are
shown within DAPI stained cell nuclei (blue).
Epithelial cells are above a matrix containing
fibroblasts as shown and images scored for number
of total cells, % of foci positive cells and number of
foci per cell for each cell type.

Doses: 0, 0.1 and 2 Gy
Radiation quality: Fe 600 MeV/n irradiated at BNL
Timepoints: 2, 24, and 72 hours post exposure
Analysis: Images were adjusted for fluorescent intensity equally between images using imageJ.
Figure 8 shows a representative OTC image 2 hr post a 0.1 Gy dose.
All images were coded and scored blindly.
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Data obtained from each image include:
1) Total number of DAPI positive cells in the epithelial and fibroblast layers
2) Percentage of foci positive cells in the epithelial and fibroblast layers
3) Total number of foci in each foci-positive cell in epithelial and fibroblast layers.

2.7 53BP1 Kinetics in Human Esophageal Organotypic Cultures Following
Fe 600 MeV/n Exposure
To examine the DNA damage response and repair kinetics as defined by 53BP1 foci in threedimensional (3D) human esophageal organotypic cultures (OTC) following high LET Fe 600
MeV/n radiation. This work will be compared to similar OTC stained for gH2AX, another DNA
damage marker, to define similarities and differences.
Human OTC were prepared by our collaborators (Dr. Rustagi) at the University of Pennsylvania
using human esophageal cells. Human esophageal epithelial cells OTC were fixed, paraffin
embedded and sectioned onto slides. Slides were then processed and stained using an antibody
against 53BP1, a protein known to be recruited to sites of DNA double-strand breaks (DSB).
Staining and imaging of the OTC sections were done at LBNL, but were analyzed and quantified
in the present study.
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Figure 9. OTC section stained for 53BP1 foci 72
hours post 2 Gy. 53BP1 foci are labeled with Alexa
488 (green) and cell nuclei are counterstained with
DAPI (blue). Division between Epithelial and
fibroblast layers is noted with yellow line on OTC
image.

Doses: 0, 0.1 and 2 Gy
Radiation quality: Fe 600 MeV/n
Timepoints: 2, 24, and 72 hours post exposure
Analysis: ImageJ was used to quantify fluorescently tagged 53BP1 foci within the DAPI stained
cells. Epithelial and fibroblast layers were scored separately to define differences in radiosensitivity between each cell type. Figure 9 shows a representative OTC image 72 hr post a 2 Gy
Fe 600 MeV/n exposure. Slides were scored blindly.
Data obtained from each image analyzed included:
1)Total number of DAPI positive cells in the epithelium and fibroblast layers
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2) The percent of foci positive cells
3) The number of foci per cell

2.8 Statistical analysis
Data were analyzed and graphed using GraphPad Prism version 8, with the exception of Milliplex
multiplex assay. Statistical significances were calculated using one-way ANOVA. Values were
considered significant when the p-value was below 0.05.
Multiplex assay data were shared with a statistician who determined significance, and are
denoted *p<0.05; **p<0.01; *** p<0.001; **** p<0.0001; p=0.06 also noted as close to
significant.

34

CHAPTER 3

RESULTS
3.1 Dose and Radiation Quality Effects Using Mouse Esophageal Organoids
Organoids within the H&E sections for each treatment group were first measured for the
thickness of whole cell layer (Figure 4B). The whole cell layer constitutes both the basal and
suprabasal layers. A significant dose and radiation quality dependent increase in the thickness of
the whole cell layer was observed following high LET (Fe 600 MeV/n) exposure (Figure 10).
Significant differences were noted between organoids exposed to 0 and 1 Gy Fe 600 MeV/n
(p<0.05). Interestingly, low LET (Cs) exposed organoids demonstrated a similar dose response
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Figure 10. Dose and radiation quality dependent changes in the thickness of mouse
esophageal organoid tissue layers following radiation. Mouse esophageal epithelial cells
were used to set up organoids and exposed to various doses (0.1 and 1 Gy) of Fe 600 MeV/n or
Cesium. The thickness of whole layer (as defined in Figure 1) was quantified following the
different doses and radiation quality exposures. Significant differences are noted between 0
and 1 Gy Fe 600 MeV/n exposure (p=0.015).
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Next, the most outer basal, single cell layer (Figure 11A) of the organoids was measured.
The “single cell layer” measurement represents the average size of the basal layer. The thickest
portion of this outer single cell layer was measured. The thickness of the single cell layer (as
defined in Figure 4B) was quantified following different doses and radiation quality exposures.
No significant changes were observed in the average thickness of this single basal cell layer
following high LET (Fe600 MeV/n) or low LET Cs exposure as compared to controls (Figure
11A).
Next, we analyzed the total length (Figure 11C) and width (Figure 11D) of the organoids
to evaluate overall size changes. No significant changes were observed in the average length and
width of organoid following high LET (Fe600 MeV/n) exposure as compared to control organoids.
However, a non-significant increase was observed in the width of the diameters as dose increased
(Figure 11D). No significant changes were observed in either length or width following Cs
exposure, although the highest dose did show in both cases an increase over the control and lower
dose. Lastly, the lumen was analyzed for differences between the different radiation qualities and
controls. The lumen is the area of the esophagus where differentiated cells are sloughed off and
discarded. The lumen (as defined in Figure 4B) was measured following the different doses and
radiation quality exposures. The average diameter of lumen for the high LET (Fe600 MeV/n) 0.1
Gy exposed organoids demonstrated a non-significant increase in size as compared to controls.
Whereas a non-significant decrease was observed for organoids exposed to 1 Gy Fe600 MeV/n as
compared to 0.1 Gy. (Figure 11B). Similarly, Cs exposed organoids revealed a similar trend with
a non-significant increase between 0 and 0.1 Gy and non-significant decrease between 0.1 and 1
Gy.
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Figure 11. Other measurements of mouse esophageal
organoids following Fe 600 MeV/n or Cesium
exposure. The most outer basal single cell layer was
measured (A), or the internal lumen diameter (B) or the
total length (C) or width (D) was measured for each
organoid for each dose and radiation quality.

3.2 Dose-response of MAPK/SAPK Signaling in Mouse Esophageal Organoids in Response
to Fe 600 MeV/n Exposure
In this work a multiplexed assay was used to define the expression of 10 phospho-proteins in the
MAPK/SAPK stress pathway (Figure 5). The exact phospho-sites are detailed under the
methods section. To first define the dose-response of stress pathway phospho-protein expression
patterns following Fe600 MeV/u irradiation, we determined the fold change following each dose
as compared to sham irradiated samples. We then grouped the fold change of phospho-proteins
showing similar increasing or decreasing trends following a low (0.1 Gy) or a higher (1 Gy)
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dose. Folds > 1.1 were designated as having an increasing trend and those less <0.9 a decreasing
trend, whereas folds between these two were categorized as unchanged (Appendix I).
In Figure 12 we graph those showing similar trends for a low vs. a higher dose exposure. No
significant changes in the expression of any phospho-sites with either a low or a higher dose as
compared to sham was observed. However, following 0.1 Gy irradiation, we do observe a similar
trend for a group of phospho-proteins of an increased expression at the low dose, including
Erk/MAPKinase 1/2, p53, MEK1, and MSK1 (Figure 12A). The remaining phospho-proteins
(ATF2, JNK, HSP27, p38, STAT-1, and c-Jun; Figure 12B) showed a very minor change in fold
expression (>1.1 or < 0.9). Following a higher 1Gy exposure, a decrease in expression was
observed for a number of phospho-proteins that had shown the opposite trend at the low dose
(Erk/MAPKinase 1/2, p53, and MEK1) as well as two additional phospho-proteins (p38 and cJun, Figure 12C). Similarly, we also observed for the higher dose no major fold change in the
same phospho-proteins unaltered at a lower dose (ATF2, JNK, HSP27, and STAT1) as well as
no change in one that had revealed an increased expression at a low dose (MSK1, Figure 12D).
When comparing expression patterns between all doses, a dose-dependent decrease was
observed for the expression of phospho-protein p38 (Figure 12E). In addition, three phosphoproteins showed a trend in which the lower dose had a greater level of expression than a higher
dose (Erk/MAPKinase ½, p53, and MEK1) (Figure 12F).
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Figure 12. Dose-response expression of phospho-protein’s in the
stress pathway in human esophageal organoids. Phospho-proteins
showing a trend of increased expression with low dose radiation (0.1
Gy; (A) and those showing no major fold change (folds between 0.91.1; (B). Following a higher dose (1 Gy) proteins showing a trend of
decreased expression (C) and those showing no major fold change
(D). One phospho-protein, p38, showed a dose dependent decrease
(E) and three phospho-proteins showed the highest expression level
at a low dose (F). A significant difference in Erk/MAPK expression
is noted with a low vs. a high dose, p<0.05.
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Figure 13. Effect of ATM inhibition on expression of stress pathway phospho-proteins. Phospho-protein
expression for Sham IR samples, without (blue bar) and with the ATM inhibitor (beige bar) showing a
decreasing trend (A), of note HSP27 and p38 show a significant decrease. The remaining sham IR showed no
major fold change (B). Following the low 0.1 Gy exposure, phospho-proteins showing a decreasing trend (C)
are noted, with p53 showing a significant decrease. p38 was the only phospho-protein at a low dose showing a
slight increase (D) with ATM inhibition. The remaining phospho-proteins following a low dose showed no
change (E) in comparing sham to +ATMi samples. Lastly, phospho-proteins following a higher 1 Gy dose
which showed a decreasing trend with ATM inhibition (F) were graphed together, with ATF2 showing a
significant decrease. A slight increase with 1 Gy and inhibitor as compared to no inhibitor was only observed
with Erk/MAPk (G) and no change was observed with the remaining phospho-proteins (H) as compared to 1 Gy
exposure alone. Dose-dependent trends were only noted for ATF2 (I) which showed a decrease with dose, note
blue is level expressed with ATMi and beige portion additional expression in control samples without inhibitor
for each dose. *denotes p<0.05 and ** p<0.01.
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To better understand the role of ATM in the stress response to radiation we used an ATM
inhibitor to define how phospho-protein expression patterns changed as compared to no inhibitor
at each dose and sham. Without radiation exposure, a number of phospho-proteins decreased as
compared to sham (Figure 13A; HSP27, p38, Erk/MAPKinase ½, p53, MEK1, MSK1, and
STAT1), with HSP27 and p38 showing a significant decrease + ATMi as compared to sham.
Three phospho-proteins showed no major fold change (ATF2, JNK, and c-Jun) +/- ATMi
(Figure 13B). When comparing phospho-protein expression with ATMi following a low 0.1 Gy
dose, most phospho-proteins, similar to no dose, showed a slight decrease in expression (Figure
13C), with p53 showing a significant decrease. Unique to the low dose, one phospho-protein,
p38, showed a slight increase (Figure 13D), and no change was observed with the remaining
phospho-proteins (Hsp27, MSK1, STAT1, Figure 13E). The decreased expression observed
with addition of the ATM inhibition implies ATM is important in increasing the expression
levels of these phospho-proteins, particularly p53 following a low dose. Moving to a higher 1 Gy
dose in the presence of the ATMi resulted in fewer phospho-proteins showing a decrease in
expression (ATF2, HSP27, and STAT1; Figure 13F), with only ATF2 showing a significant
decrease. One phospho-protein showed a slight increasing trend in expression, Erk/MAPK
(Figure 13G), and the rest showed no major fold change (Figure 13H) following a 1 Gy dose.
Comparing across doses, a dose dependent trend was observed only for ATF2 (Figure 13I), with
increasing dose causing a decrease in its expression with ATM inhibition. This would suggest
that ATM is important in increasing the expression of this phospho-protein in a dose-dependent
manner.
TGFb, a cytokine that epithelial and fibroblast cells within tissues often express
following radiation, was added to esophageal organoid samples to define how the expression of
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phospho-proteins in the stress pathway would be affected following a low vs. high dose. In the
absence of radiation, the addition of TGFβ in most cases caused a decrease in phospho-protein
expression (Fig 14A and B), or in just one case, MSK, no change in expression (Figure 14C).
The majority of phospho-proteins also showed a decrease in expression following a low 0.1 Gy
dose exposure (Figure 14D), or no change in expression (Figure 14E) with the addition of
TGFb as compared to sham. Following a higher 1 Gy dose, many phospho-proteins also showed
a decrease in expression (Figure 14F) or no change (Figure 14G), although for p53 there was an
increase following 1 Gy exposure (Figure 14H). In looking at the response over the range of
doses only Hsp27 showed a dose-dependent increase (Figure 14I) in expression with
TGFb addition.
To gain further insight into the role of TGFb in the stress pathway following radiation,
we also inhibited TGFb with the addition of SD208, a specific TGFb inhibitor. With no dose, we
observed a decrease in expression of a number of phospho-proteins (ATF2, Erk/MAPK, MEK1,
STAT1, c-Jun; Figure 15A), an increase in the expression of JNK (Figure 15B), or no change in
a sub-set (Hsp27, p38, p53 and Msk1; Figure 15C). Following a low dose, the majority of
phospho-proteins also showed a decrease in expression (Figure 15D and E), with only JNK
(Figure 15F) showing a slight increased expression following a low dose. Following the higher
dose, a decreased expression of a number of phospho-proteins was observed (ATF2, JNK,
HSP27, MEK1, STAT1; Figure 15H). A few phospho-proteins showed an increase (Figure
15G), or no major fold change (Figure 15I).
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Figure 14. Effect of TGFβ addition on MAPK/SAPK phospho-protein expression following various doses
of Fe600 MeV/n. Phospho-proteins showing a decreased fold expression with TGFβ addition (A), with a
significant decrease note for p38 as compared to sham (B). Those failing to show a major fold change as
compared to sham (C). Phospho-proteins showing a slight decrease (D) or no change (E) following 0.1 Gy
irradiation in the presence of TGFb compared to sham. Phospho-proteins showing a decrease with TGFβ
addition (F) with a 1 Gy dose, or no change (G), or in one case an increase, as noted with p53 (H). Over the
range of doses, only one phospho-protein exhibited a dose dependent response, HSP27, exhibiting a dosedependent increase with TGFb addition. Dark aqua portion of the bar is the level induced + TGFb and the dark
gray the difference in the expression as compared to control level at each dose (I). *p<0.05 and **** p<0.0001.
Note control p53 sample +TGFb missing due to technical issue in sham sample.
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In comparing responses across all doses only Hsp27 showed a dose-dependent pattern of
decreasing levels with increasing dose when TGFb was inhibited (Figure 15J), which was
opposite the pattern observed when TFGb was added (Figure 14I).

Figure 15. Effect of TGFβ inhibition on expression of phospho-proteins in the MAPK/SAPK stress
pathway. Phospho-proteins showing a decrease with TGFβ inhibition (A), an increase (B), or no change as
compared to sham (C). Phospho-proteins showing a slight decrease (D and E) and those showing an increase
(F) with TGFβ inhibition plus a 0.1 Gy dose as compared to 0.1 Gy alone. Phospho-proteins showing an
increase, in expression +TGFβ inhibition following a 1 Gy dose (G), or a decrease (H) or no change (I) as
compared to 1 Gy alone. Looking at the response over the range of doses only Hsp27 showed a pattern of
decreasing expression with increasing dose, dark portion of bars is amount expressed + TGFb inhibition and
light section amount additionally induced in control samples, exposed to sham or dose alone (J).
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To uncover potential cross talk between the ATM and TGFb pathways, we then also
inhibited both ATM and TGFβ and observed how phospho-protein expression in the stress
pathway changed with a low vs. a higher dose. In the sham irradiated samples, we observed for
all phospho-proteins a decrease in expression (Figure 16A) with a few showing no major fold
change in their expression relative to control (ATF2, p53, and MEK1; Figure 16B). Comparing
the expression following 0.1 Gy exposure, again for the majority we observed a decrease in
expression (Figure 16C) with only two (p53 and MEK1, Figure 16D) showing no change in
expression. Following a 1 Gy exposure, we observed fewer phospho-proteins showing a decrease
in expression (ATF2, MSK1, and STAT1; Figure 16E), with a few showing an increasing trend
in expression (JNK, p53, cJun; Figure 16F), and the remainder showing no change (Figure
16G). When looking across doses two phospho-proteins showed some dose-dependent responses
(Figure 16H and I). Hsp27 showed a dose-dependent increase in response (Figure 16H), which
was opposite of what was observed with TGFb inhibition alone (no dose-dependent trend was
observed with ATM inhibitor alone). MSK1 showed a pattern of decreasing levels with
increasing dose in the presence of both inhibitors (Figure 16I) which was not observed with
either inhibitor separately.
To define whether unique patterns are observed with addition of both inhibitors,
suggesting cross-talk between the pathways, we graphed control, +ATMi, +TGFbi and the
combined inhibitor exposure (Figure 17) together. Following no dose, a number of
phospho-proteins in the presence of both inhibitors expressed levels similar to ATMi alone
(Hsp27, p38, ATF2 and MSK1; Figure 17A). A few behaved similarly to TGFbi alone
(Erk/MAPK, p53, and Stat1; Figure 17B) and three showed unique patterns MEK1, JNK and c-
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Jun (Figure 17C), suggesting TGFb and ATM may co-regulate their expression in the absence of
radiation exposure.
Following a 0.1 Gy exposure, unique expression patterns in the presence of both inhibitors were
observed for MEK1, p53, p38, MSK1 and STAT1, with levels differing from either +ATMi or
+TGFbi addition alone (Figure 17G & H). Lastly, following a 1 Gy dose, three phospho-proteins
showed unique responses (JNK, p53 and MSK1, Figure 17K), differing from either inhibitor
alone.
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Figure 16. Combined effect of ATM and TGFβ inhibition on the expression of phospho-proteins in
the MAPK/SAPK stress pathway. The majority of un IR samples showed a decrease in phosphoproteins expression with the addition of the combined inhibitors (A) with Hsp27 and p38 showing a
significant decrease. A few samples also showed no change as compared to no dose alone (B). Following a
low 0.1 Gy exposure again most phospho-proteins showed a slight decrease (C), with Erk/MAPK showing
a significant decrease. Only two phospho-proteins, showed no change in expression with the addition of
the combined inhibitors (D) as compared to 0.1 Gy exposure alone. Following a higher 1 Gy dose, fewer
phospho-proteins showed a slight decrease with the addition of both inhibitors (E), with three showing an
increase (Jnk, p53 and c-Jun; F) or no change (G) as compared to 1 Gy exposure alone only. Comparing
responses across the entire dose range, a dose-dependent increase was observed for HSP27 (H) and a dosedependent decrease with MSK1 (I ) with the addition of both inhibitors as compared to sham * p<0.05.
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Figure 17. Combined effect of ATM and TGFβ inhibition on the expression of
phospho-proteins in the MAPK/SAPK stress pathway compared to single inhibitors
or sham. Without radiation exposure the majority of phospho-proteins showed a similar
expression as +ATMi samples alone (A), with a few showing a similar expression to
+TGFβi alone (B). Unique responses with no dose were observed for MEK1 and cJun (C),
as well as JNK (D). With a low 0.1 Gy exposure again many phospho-proteins expressed
levels similar to +ATMi alone (E) or +TGFβi alone (F). Unique responses were observed
for MSK1, STAT-1, p53, MEK1 (G) and p38 (H). Following a higher 1 Gy dose, more
phospho-proteins showed expression levels similar to +ATMi alone (I), with two phosphoproteins expressing levels similar to +TGFβi alone (J). Unique responses were observed
for JNK< p53 and MSK1 with combined ATM and TGFβ inhibition and a 1 Gy exposure
(K).
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Table 1. Patterns of stress phospho-protein expressions with combined inhibitors
No Dose
Like ATMi Hsp 27, p38, ATF2, MSK1
Like TGFbi Erk/MAPk, p53, STAT 1
Unique
MEK1, JNK, c-Jun

Low Dose
JNK, ATF2, c-Jun
Hsp 27, Erk/MapK
p53, MEK1, p38, MSK1, STAT1

High Dose
STAT1, Hsp27, P38, MEK1, Erk/MAPK
ATF2, c-Jun
JNK, p53, MSK1

3.3 A Comparison of SAPK/MAPK Phospho-Protein Response in Human and Mouse
Esophageal Organoids Following Different Radiation Qualities
The aim of this study was to understand the impact of dose and radiation quality on esophageal
tissue’s stress response and how this may differ between species. Mouse and human organoid
samples were used to study persistent effects on the MAPK/SAPK stress pathway (nine days
post exposure) following either a low or high LET radiation exposure (cesium vs. Fe 600
MeV/n). A multiplexed assay was used to define the expression of 10 phospho-proteins in the
MAPK/SAPK stress pathway (Figure 5).
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Figure 18. MAPK/SAPK stress phospho-protein dose-dependent expression 9 days post Fe 600 MeV/n
exposure in human esophageal organoid samples. Graphs compare phospho-protein expression levels and
reveal patterns in fold change. Phospho-proteins showing a fold increased fold (A), decrease fold (B and C), or
no change (D) following 0.1 Gy as relative to controls. Following a higher 1 Gy dose phospho-proteins
showing an increased fold (E and F), decreased fold (G), or no change (H) relative to controls. Graphing
average expression across doses reveals increasing dose-dependent expression of ATF2 (I) whereas p38
dependent decrease in expression (J). Significant differences were noted between the doses for p53 (K),
Erk/MAPk (L) and c-Jun (M), with *p<0.05; **p<0.01; *** p<0.001; **** p<0.0001.

We first compared expression patterns following exposure to the high LET radiation
quality Fe 600 MeV/n in human esophageal organoid samples 9 days post exposure (Figure 18).
Following a low 0.1 Gy dose, we observed ATF2, STAT-1, and c- Jun phospho-proteins to
increase in expression as compared to sham (Figure 18A), with c-Jun significantly elevated from
sham (p=0.001). Whereas phospho-proteins p53, MEK1, p38, and Erk/MAPK all revealed a
decrease in expression as compared to sham (Figure 18B and 18C), with Erk/MAPK
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significantly decreased (p=0.01) as compared to sham. A few phospho-proteins revealed no
major change in expression (JNK, HSP27, and MSK1) between the irradiated sample and control
(Figure 2D). Following a higher 1 Gy dose, ATF2, STAT1 and c-Jun showed an increase in
expression, similar to the low dose. Unique to the higher dose nearly all phospho-proteins
showed an increase in expression (Figure 18E and 18F). Opposite patterns were noted between
the low and high dose for p53, Mek1, and Erk/MAPK, which all decreased in expression
following the low dose and increased in expression following a high dose as compared to sham.
Expression of p38, similar to the low dose was decreased compared to sham following 1 Gy
exposure (Figure 18G). Phospho-protein JNK, was the only phospho-protein to remain
unchanged following the 1Gy exposure (Figure 18H). When comparing expression patterns
between all doses, a dose-dependent increase was noted for ATF2 (Figure 18I), while a dosedependent decrease was noted for phospho-protein p38 (Figure 18J). In addition, a significant
difference between the low and high dose was noted for p53 (Figure 18K), and Erk/MAPK
(Figure 2L), with expression being much more elevated following the high dose. The opposite
pattern was observed for c-Jun with the low dose significantly elevated from the high dose
(Figure 18M).
To better understand radiation quality differences in the expression of phospho-proteins
in the stress MAPK/SAPK pathway, human esophageal organoids were studied following low
LET cesium exposure at the same doses. When comparing fold changes for 0.1 Gy vs. sham, we
noted an increase in the expression of phospho-proteins, ATF2, HSP27, STAT-1, and c-Jun
(Figure 19A), and a decrease in JNK, MSK1, p38, and Erk/MAPK expression compared to sham
(Figure 19B and 3C). The remaining phosphoproteins, p53 and MEK1, remained unchanged
from sham nine days post 0.1 Gy Cs irradiation (Figure 19D). Moving to a higher 1 Gy dose, an
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increase as compared to sham was noted again for phospho-proteins ATF2, STAT1, and c-Jun
(Figure 19E). Whereas phosphoproteins JNK, HSP27, MSK1 and p38 all showed a decreased as
compared to sham (Figure 19F-G). No change was observed for phospho-proteins Erk/MAPK,
p53, and MEK1 (Figure 19H - 3I). Comparing across doses, we noted a dose-dependent
decrease for phospho-protein JNK (Figure 19J). Erk/MAPk also showed a significant difference
between the low and high dose, similar to what was observed following high LET, although the
low dose showed an even greater decrease from sham as well (Figure 19K).

Figure 19. Impact of cesium exposure on MAPK/SAPK phospho-protein expression nine days post
exposure in human esophageal organoid samples. Phospho-proteins showing a fold increase (A), fold
decrease (B and C) or no change (D) following 0.1 Gy compared to sham. Following a higher 1 Gy Cs exposure,
phospho-proteins showing a fold increase (E), fold decrease (F and G), or no change (H and I) compared to
sham. Lastly, looking at expression across the doses, JNK showed a dose-dependent decrease (J), ATF2, Hsp27,
MEK1, STAT1, and c-Jun, p38, p53 and MSK1 showed similar levels between doses (K - M), and Erk/MAPK
showed a significant difference between the low and high dose (L), *p<0.05; **p<0.01; *** p<0.001; ****
p<0.0001.
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Given many studies have been performed using mouse models, and data often need to be
extrapolated from mouse to human, it is important to understand similarities and differences
between these species. Thus, we also defined how the same radiation qualities impacted mouse
esophageal organoid phospho-protein MAPK/SAPK expression. Uniquely in mouse organoids,
following the low 0.1 Gy dose, we observed an increased expression for all phospho-proteins
(Figure 20A and 20B) except Erk/MAPK (Figure 20C), which remained unchanged. Following
a higher 1 Gy dose, we again observed an increase in the expression of nearly all the phosphoproteins (Figure 20D and 20E) with the exception of STAT-1 (Figure 20F), which showed a
decrease as compared to sham.
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Figure 20. MAPK/SAPK phospho-protein dose-response in mouse esophageal organoids
nine days post Fe600 MeV/n exposure. Following the 0.1 Gy dose the majority of phosphoproteins showed an increased fold in expression (A and B) or no change (C) as compared to
sham. Following a higher 1 Gy most showed an increased fold change (D and E), or in one
case a decrease (F) as compared to sham. When comparing expression across doses a few
showed a dose dependent increase in expression (G, H and I). Significant differences were
noted between the doses for Erk/MAPK (J) with the higher dose showing the greatest values.
Four other phospho-proteins revealed the lower dose to be significantly higher than the high
dose (K), *p<0.05; **p<0.01; *** p<0.001; **** p<0.0001.
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Figure 21. Cesium’s impact on mouse esophageal organoid MAPK/SAPK
stress pathway signaling nine days dose post exposure. The majority of
phospho-proteins following Cs exposure were significantly increased following
0.1 Gy as compared to sham (A-B), with only p38 showing no notable fold change
(C). Following a higher 1 Gy dose, a number of phospho-proteins showed
significant increases over control (D), but two showing a decreased fold (E) and
two showing no major fold change from control (F). Viewing phospho-protein
expression patterns across doses, a common pattern is for the low dose to show the
greatest expression (G and H) *p<0.05; **p<0.01; *** p<0.001; **** p<0.0001.

Likewise, we compared MAPK/SAPK phospho-expression in the mouse esophagus
organoid tissue following low LET cesium exposure (Figure 20). Again, similar to the high LET
results, following the low 0.1 Gy exposure the majority of the phospho-proteins showed an
increased fold expression (ATF2, HSP27, p53, MEK1, MSK1, STAT1, c-Jun, JNK, and
Erk/MAPK) as compared to sham (Figure 21A-B). The only protein not showing an increase was
p38 which did not notably change in expression levels between the 0.1 Gy exposure and sham
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(Figure 21C). At the higher 1 Gy dose, we also observed an increased fold in the majority of
phospho-proteins (Figure 21D), although two phospho-proteins, p38 and Erk/MAPK, showed a
decreased fold change in expression as compared to sham (Figure 21E). Two phospho-proteins,
STAT-1 and c-Jun remained basically unchanged following 1 Gy exposure as compared to sham
(Figure 21F). Interestingly, a pattern observed following the Cs exposure in the mouse organoid
samples was higher phospho-protein expression levels post the low dose levels as compared to
sham or the high dose (Figure 21G-H).
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Figure 22. A comparison of radiation quality differences in SAPK/MAPK phospho-protein expression in
human esophageal samples. Phospho-protein expression following 0.1 Gy (Figure A-C) or 1 Gy (Figure D-F)
of cesium or Fe 600 MeV/n.
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To directly compare radiation quality effects in the human organoid samples, we graphed
the fold expression changes relative to sham for proteins in the MAPK/SAPK pathway for both
radiation qualities (Figure 22). Following 0.1 Gy, the expression of JNK, MSK1, STAT1, c-Jun,
and Erk/MAPK was higher for Fe600 (22A-B). Yet, the expression of HSP27, p53, and MEK1
was higher following 0.1 Gy Cs (Figure 22C). Phospho-proteins ATF2 and p38 (Figure 22D)
revealed similar expression levels between radiation qualities. At the higher 1 Gy dose, Fe 600
MeV/n showed higher levels as compared to cesium for the majority of the phospho-proteins
(ATF2, JNK, HSP27, p53, MEK1, MSK1, STAT1, and Erk/MAPK; Figure 6E-F). Only
phosphoprotein p38 had a slightly greater expression following 1 Gy of cesium as compared to
Fe600 (Figure22E). A similar expression level between the radiation qualities was observed for
c-Jun following the 1 Gy dose (Figure 22H).
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Figure 23. Comparison of radiation quality differences in mouse esophageal
MAPK/SAPK phospho-protein expression nine days post Fe600 or Cs exposure.
Phospho-protein fold expression changes relative to sham following 0.1 Gy (Figure A-C) or
1 Gy (Figure D-F) dose are shown.

We also directly compared radiation quality effects for mouse esophageal organoids following 0.1
Gy (Fig, 23A-C) and 1 Gy (Figure 23D-F) exposure of high vs. low LET radiation. Following the
low 0.1 Gy dose, a higher fold expression was observed in Fe600 irradiated samples only in p38
(Figure 23A), whereas all the remaining phospho-proteins showed either a higher expression for
cesium (Figure 23B) or no difference between the radiation qualities (Figure 23C). Following the
higher 1 Gy dose more phospho-proteins showed a higher expression with Fe 600 exposure
(Figure 23D), although ATF2, MSK1 and STAT1 were higher with cesium exposure (Figure
23E) and no difference was observed in fold between the radiation qualities for three phosphoproteins (Figure 23F).
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Figure 24. A comparison of MAPK/SAPK phospho-protein fold expression levels between human and
mouse esophageal organoids 9 days following Fe600 MeV/n. Following a 0.1 Gy dose (A-C) or a 1 Gy (D-F)
exposure. Graphed values are a fold over each respective sham irradiated value.

To gain further insight into how the expression of phospho-proteins differs depending upon
species, we compared the Fe 600 MeV/n exposed mouse vs. human samples as a fold over each
species respective control (Figure 24). In comparing results following a low 0.1 Gy exposure we
observed only one phospho-protein, c-Jun, to be induced to a higher level in humans as compared
to mice, with the majority of phospho-proteins more highly expressed in mice (Figure 22B). Two
phospho-proteins, ATF2 and STAT1 showed similar levels of induction for both human and mice
esophageal 3D organoids (Figure 22C). Following a higher 1 Gy dose, again human samples only
showed a higher expression for a couple of phospho-proteins, ATF2 and STAT1 (Figure 22D),
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with the majority of phospho-proteins being more highly expressed in mice (Figure 22E), and a
few being approximately equally induced in both species (Figure 22F).
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Figure 25. Comparison of SAPK/MAPK phospho-protein expression levels in esophageal organoids
between species following cesium exposure. Graphs are plotted as a fold over each species respective control
with graphs (A-B) showing effects 9 days post a low 0.1 Gy dose and graphs (C-E) showing expression post a
higher 1 Gy dose.

Species differences were also compared following cesium irradiation (Figure 25). Exposure
to the low 0.1 Gy dose resulted in all phospho-proteins showing a higher expression (Figure 25A)
for mice as compared to humans, with the exception of STAT1 which had approximately the same
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level of expression between the species (Figure 25B). Following the higher 1 Gy dose, a few
phospho-proteins showed a higher expression in human samples including Erk/MAPK, STAT-1,
and c-Jun (Figure 25C). Nevertheless, the majority of the phospho-proteins still showed a higher
expression for mouse samples as compared to human (Figure 25D), with only p38 revealing
expression levels that were approximately the same between the species following a 1Gy dose of
cesium (Figure 25E).

3.4 Radiation Quality and Dose-dependent Effects on Persistence of gH2AX in Mouse
Esophageal Organoids
To quantitatively define persistent effects in esophageal epithelial cells following Fe 600 MeV/n
and Cs exposure, esophageal organoids were exposed to radiation. Table 2 shows the number of
foci positive cells compiled for each organoid and presented as a percentage of foci positive cells
per total number of cells within the organoid.

Table 2. Dose and Radiation quality dependent number of Foci positive cells per organoid
Dose (Gy)
Number of slides
Average foci positive
Mouse Organoid
cells/organoid
Fe600 MeV/n
0 Gy
11
6.24
0.1 Gy
11
5.15
1 Gy
9
9.18
Cs
0 Gy
5
8.59
0.1 Gy
5
10.00
1 Gy
5
20.83
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We first detailed levels of gH2AX foci in esophageal organoids following Fe600 MeV/n
irradiation, a high LET ion that produces damage more difficult to resolve (Nickoloff et al. 2020).
Organoids were exposed to both a low (0.1 Gy) and higher (1 Gy) dose. The percentage of γH2AX
foci positive cells/organoid were then compiled for both doses. For the lower dose slightly fewer
gH2AX foci positive cells were observed as compared to sham, although the difference was not
significant (Figure 26, left). But in comparing 0.1 Gy to 1 Gy there was a slight, although nonsignificant increase between these doses. Thus, a higher 1 Gy dose of high LET radiation causes a
slightly higher level of persistent gH2AX foci as compared to the lower 0.1 Gy dose nine days post
exposure.
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Figure 26. The percentage of γH2AX positive cells in mouse
esophageal organoids following high (left) vs. low LET
(right) radiation. The percent of foci positive cells per
organoid is displayed +/- SE.**p<0.004, *p<0.01

Organoids were also irradiated with cesium to provide a low LET comparison to the high
LET exposure. With this exposure a dose-dependent response is observed, with even the lower
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dose showing a slight, although non-significant elevation in the percentage of gH2AX foci/
organoid as compared to the control (Figure 27, right). However, at the higher 1 Gy dose there
was a significant elevation in the number of foci positive cells/organoid, revealing significant
differences between both the sham and the 0.1 Gy dose. These results suggest more foci positive

Fold: γH2AX Foci+ Cells per Organoid

cells remain following the low LET exposure as the background levels in sham are fairly close.
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Figure 27. Fold increase in gH2AX foci positive
cells per organoid for each dose and radiation
quality.

To directly compare between the radiation qualities, we normalized data based on each
respective control level, plotting the percentage of gH2AX foci positive cells as a fold over their
controls (Figure 27). This revealed again an increase in the percent of gH2AX foci/organoid at
both doses in the Cs samples as compared to the Fe600 MeV/n samples. Epithelial cells within
mouse organoids exposed to Cs had ~2.5 times more foci positive cells than did Fe ion exposed
cells nine days post exposure (2.4-fold for low 0.1 Gy dose and 2.7-fold for high 1 Gy dose).
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3.5 Persistence of 53BP1 Foci in Mouse Esophageal Organoids
To define how radiation quality impacts esophageal tissue, esophageal organoids were exposed to
either Fe600 MeV/n or Cs and the average number of 53BP1 foci positive cells/organoid defined
(Table 3). The average number of cells within organoids showing pan staining were also defined.

Table 3. Dose and Radiation quality dependent number of Foci positive cells based on surface
area of the organoid
Dose (Gy)
Number of slides
Pan stained
Average
Mouse
foci/organoid
Organoid
Fe600 MeV/n
0 Gy
17
4.50
0.55
0.1 Gy
58
16.65
1.37
1 Gy
130
15.62
1.64
Cs
0 Gy
91
8.50
0.83
0.1 Gy
52
15.63
1.11
1 Gy
86
9.03
1.47

Focusing first on high LET Fe600 MeV/n results, we noted that mouse organoids revealed a
dose dependent increase in the average number of foci positive cells per organoid (Figure 28, left)
with both doses showing a fairly equal increase over control, with the 0 vs. 1 Gy comparison being
significantly different. In contrast, cesium irradiation exhibited more of a dose response, with
significant increases in the average number of foci positive cells between sham and both doses as
well as between the doses. Both Fe and Cs exposures produced very similar levels of 53BP1 foci
positive cells per organoid following the higher dose, whereas at the lower dose Cs produced less
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foci positive cells per organoid than Fe. Of note as well is the elevated baseline levels in the cesium
control as compared to the Fe ion sample.
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Figure 28. Average number of 53BP1 foci positive cells per
mouse esophageal organoid following different radiation quality
exposures. The average number foci positive cells per organoid was
quantified following Fe600 MeV/n or Cs exposure, ***p<0.0001,
**p<0.001, *p<0.03.

Conversely, in comparing radiation quality effects for the average number of pan-stained
cells/organoid we noted some differences between radiation qualities (Figure 29). Following Fe
ion exposure, similar to the average foci/organoid, the pattern appears to be an increase with both
doses, but no dose response. In contrast, cesium exposed organoids showed a very different
pattern, with the average number of pan-stained cells/organoid being significantly elevated at the
lower dose as compared to the higher 1 Gy dose. In addition, sham is fairly high, and higher than
high dose levels.
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Figure 29. Average number of pan stained cells per mouse esophageal
organoid following different radiation quality exposures. The average
number foci pan-stained cells per organoid was quantified for Fe 600 MeV/n or
cesium,*p<0.03, **p<0.003.

To allow a direct comparison between the radiation qualities we normalized results by providing
the fold over the control values for each endpoint, using each respective control (Figure 30). In
comparing average 53BP1 foci positive cells per organoid as a fold over control we note that Fe
600 MeV/n exposed samples at both doses showed a greater number of persistent foci. For both
Fe and Cs we additionally saw a slight increase with dose as well for foci positive cells/organoid.
Similarly, for the average number of pan-stained cells per organoid as a fold over control we
observed higher levels for the Fe ion exposed organoids. However, for pan-stained cells we failed
to see a dose-dependent increase, and instead following Fe exposure we observed fairly equal
levels between the doses, whereas following Cs exposure we saw much lower levels with the lower
dose being slightly higher than the high dose.
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Figure 30. Comparison of Radiation quality differences in 53BP1
foci positive cells or pan-stained cells per mouse esophageal
organoids following exposure. The average number of 53BP1 foci
positive cells/organoid are shown as a fold over control levels (left).
The average number of pan-stained cells/organoid is shown as a fold
over control levels (right).

3.6 gH2AX Kinetics in Human Esophageal Organotypic Cultures Following Fe 600 MeV/n
Exposure
Defining the kinetics of gH2AX change over time allows us to determine how well a tissue is
able to cope with the initial damages induced by a particular radiation quality, in this case Fe 600
MeV/n. The total number of cells and the percentage of gH2AX positive cells were defined for
both the epithelial and fibroblast layers of human esophageal OTC (Table 4). Images taken were
centered on the epithelial portion of the section; thus, less information was available for the
fibroblast cells (fewer fibroblast cells visible in images, Table 4). Data were compiled for the
foci positive cells as a percentage of the total cells within each layer of the OTC section at each
timepoint.
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Table 4. Percentage of gH2AX foci positive cells in the epithelium and fibroblast
layers of human esophageal OTC at 2, 24, and 72 hours post irradiation.

Timepoint

Epithelium
Layer
% of Foci+
Cells

Fibroblast
Layer
% of Foci+
Cells

(# cells with
foci/total scored)

(# cells with
foci/total scored)

3.26
(19/583)
8.0
(26/325)
20.93
(113/540)
0.50
(1/199)
2.60
(39/1499)
9.21
(43/467)
0.78
(2/255)
6.43
(34/529)
16.8
(121/720)

10.2
(5/49)
30.1
(25/83)
54.76
(23/42)
3.57
(1/28)
30.8
(8/26)
54.5
(12/22)
5.0
(2/40)
28.57
(4/14)
45.45
(5/11)

Dose (Gy)

2 hours post
irradiation

0
0.1
2

24 hours post
irradiation

0
0.1
2

72 hours post
irradiation

0
0.1
2

As might be expected, we observed a dose response in gH2AX positive cells in both tissue types
(Figure 31) at all time points. However, Fibroblast cells appeared to have a greater proportion of
foci positive cells at all time points, including sham irradiated samples. Sham levels varied for
each cell type somewhat, becoming slightly lower over time. A pattern observed following both
doses in the epithelial cells was a decrease at 24 hr timepoint as compared to the 2 hr time, but
then a slight increase at the 72 hr timepoint. This was unique to the epithelial layer as fibroblast
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gH2AX levels remained fairly unchanged for each dose over the 72-hr time period, with significant
differences noted between the fibroblast sham and 2 Gy sample at each time point.

Figure 31. Kinetics of dose-dependent changes in the percentage of foci
positive cells within the epithelial and fibroblast layers of the
esophageal OTC 2, 24, and 72 hr post Fe 600 MeV/n exposure. The
percentage of foci positive cells is shown over time for sham, 0.1 and 2 Gy
irradiated samples. ** p<0.01

To directly compare the kinetics between the cell types, we defined the fold over control
for each cell type and timepoint (Table 5). As can be observed very similar fold were exhibited
for each cell type for each dose at 2hr. Even at 24 hr the fold over controls are still very similar for
both cell types, with a larger difference only noted at the longest time point following the higher
dose. At 72 hr post exposure fibroblast have a 9-fold increase in gH2AX foci, whereas epithelial
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cells have a 21-fold increase over sham values. A visual depiction of this table is shown in Figure
32, revealing nearly identical folds at the earliest time point and a greater difference between the
cell types with time, the largest difference being evident 72 hr post 2 Gy exposure.

Table 5. Fold change in ƔH2AX as compared to respective control for each timepoint

OTC
Cell Layer
Epithelial
Fibroblast

Dose (Gy)
2hr
0.1
2.45

2
6.42

2.95

5.37

24hr
0.1

2

72hr
0.1

2

5.18

18.32

8.19

21.43

8.62

15.27

5.71

9.09

To assess whether the kinetics of repair are similar between the cells in the fibroblast and
epithelial layers, as well as similar between doses, we defined the percent of damage observed at
2hr that is still remaining at subsequent timepoints. Centering first on the epithelial cell layer
(Figure 33A), we compared kinetics following a 0.1 Gy vs. a 2 Gy exposure. Both doses showed
nearly identical patterns of decay following a low or a high dose. Interestingly, a rapid decrease in
foci in the first 24 hours is then followed by a slight increase over the next 24hr. Approximately
50% of the damage is repaired in the first ~24hr based on the elimination of gH2AX foci. By 72
hr post exposure, epithelial cells within OTC samples exposed to either a low or a high dose both
showed virtually identical levels of the percentage of foci remaining.
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Figure 32. Comparison of fold changes in
gH2AX expression as compared to controls
for each cell type and timepoint.

Comparing repair kinetics in the fibroblast layer, we did not observe a rapid decrease in
gH2AX foci the first 24 hr, as we had for epithelial cells, but rather levels stayed approximately
the same for both doses (Figure 33B). Then in the next 24-hour period (between 24-72hr) we
observed a decrease with cells exposed to the low 0.1 Gy dose showing less of a decline than cells
exposed to the higher 2 Gy dose. Thus, it appears fibroblast cells have a delay in repair as compared
to epithelial cells as neither dosed group decreased to 50% of 2hr levels during the 72 hr time
period. However, samples exposed to the high dose reached a lower value at 72 hr than the samples
exposed to a lower dose, indicating more rapid repair following a higher dose.
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Figure 33. Kinetics of gH2AX foci relative to amount induced at 2 hr post
exposure for each cell type and timepoint. Epithelial (A) or fibroblast (B)
cell gH2AX folds over control within the OTC are shown for each dose. A
comparison between the cell types following a low 0.1 Gy dose (C) or a higher
2 Gy dose (D).

To more directly compare the kinetics of repair between the two cell types, we overlayed the
percent of foci induced at 2hr remaining at each time point for both cell types. Following the low
dose exposure (Figure 33C) we saw a dramatic difference between the cell types at 24 hr where
epithelial cells reduced the percent of foci positive cells dramatically, whereas fibroblast cell levels
have virtually not changed. However, interestingly with the increase in gH2AX foci positive cells
in the epithelial cells which occurs between 24 and 72 hr, the cells show very similar levels
remaining based by 72 hr.
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Performing a similar analysis and comparison in samples exposed to the 2 Gy dose, we
observed again a more rapid removal of foci within first 24 hr in epithelial cells, whereas fibroblast
showed little change over this period (Figure 33D). However, similar to the low dose, due to the
increase in gH2AX foci positive cells in the epithelial cells during the 24-72 hr time period, we
again had very close values at 72 hr between both cell types.
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Figure 34. Number of foci positive cells per OTC based on cell-type and dose. The total number of foci
positive cells in the epithelial and fibroblast cell layers per OTC section imaged at 2, 24, and 72-hour post 0.1
and 2 Gy Fe 600 MeV/n exposure. Epithelial results at A) 2hr, B) 24hr, and C) 72hr post irradiation.
Fibroblast results at D) 2hr, E) 24hr, and F) 72hr post irradiation.

Lastly, to observe the variability in the number of foci positive cells per OTC section imaged, we
compared this for each tissue layer (Figure 34). As might be expected at 2hr post exposure more

73

OTC sections had more foci positive cells as compared to the low dose or sham. However, a very
different pattern is observed between the cell lines, with fibroblasts only having a maximum of 5
foci positive cells at the earliest time point and higher dose (Figure 34D), and epithelial cells
(Figure 34A) having a number of OTC with > 10 foci positive cells. At 24 hr post 2 Gy
exposure more epithelial cells show cells with 1-5 foci positive cells and none have OTC with
over 10 foci. Fibroblast cells within the OTC continue to reduce the number of foci positive cells
over time, having at most 2 foci positive cells at the latest time point. In contrast, epithelial cells
within OTC at 72 hr post irradiation show a very novel pattern whereby each dose group shows
distinct levels of foci positive cells. For example, sham has at most only 1-foci positive cell per
OTC section, the 0.1 Gy dose shows between 2-5 foci positive cells and the highest dose has
between 5-12 foci positive cells, with 9/13 OTC images analyzed having 10 or greater foci
positive cells. Examining the patterns reveals that between 24 and 72 hr the greatest change is
observed for epithelial cells following 2 Gy, which shows more OTC sections with a large
number of foci positive cells.

3.7 53BP1 Kinetics in Human Esophageal Organotypic Cultures
To better define how cell type and temporal kinetics vary for cells making up the OTC, the number
of determined for each cell type and timepoint and presented as a percentage of the total number
of cells observed within that tissue layer (Table 6).
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Table 6. Percentage of 53BP1 foci positive cells in the epithelium and

fibroblast layer at 2, 24, and 72 hours post irradiation.
Timepoint
Dose (Gy)
2 hours post
irradiation

0
0.1
2

24 hours post
irradiation

0
0.1
2

72 hours post
irradiation

0
0.1
2

Epithelium
Layer
% of Foci+
Cells
4.89
(43/879)
17.97
(101/562)
51.58
(539/1045)
2.5
(3/120)
7.17
(37/516)
34.48
(190/551)
0
(0/236)
3.61
(10/277)
23.91
71/297)

Fibroblast
(FEF3) Layer
% of Foci+
Cells
19.57
(9/46)
13.58
(11/81)
71.43
(35/50)
*ND
12.24
(6/49)
41.03
(32/78)
0
(0/6)
10.00
(3/30)
35
(14/40)

*This sample could not be scored due to technical issues with staining (Fibroblast 24-hour control
sample).

As can be observed, fewer fibroblast cells were present in each OTC image. For example, for every
fibroblast cell counted, 6-40 times as many epithelial cells were counted in the OTC section.
Because of this the values obtained for the fibroblast populations may not be as robust as the values
obtained for the epithelial cells.
Plotting the percentage of 53BP1 containing cells over time (2, 24 and 72 hr) in the
epithelial and fibroblast cell layers of the OTC following Fe 600 MeV/n exposure revealed time
and dose specific alterations (Figure 35).
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Figure 35. Dose and time dependent changes in the percentage of foci
positive cells within the epithelial and fibroblast layers of the esophageal
OTC at 2, 24, and 72 hr post Fe 600 MeV/n exposure. The percentage of
foci positive cells is shown over time for Sham, 0.1 and 2 Gy irradiated
samples. ****p<0.0001, ***p<0.0005, **p=0.001, *p=0.002.

For each cell type, as expected, we see the greatest percentage of foci positive cells 2-hour post
the highest dose exposure (2 Gy). A dose-dependent increase in the induction of 53BP1 foci is
noted in the epithelial layer 2-hour post irradiation, with the highest dose significantly different
from both sham and the low dose. At all-time points, for both cell types, there was a significant
difference between the control, and/or the lower 0.1 Gy dose as compared to 2 Gy. At 24 and 72
hours post exposure, we continue to observe a dose-dependent increase in foci positive cells within
the epithelial layer with percentages of foci positive cells decreasing for each dose with increasing
time. Although we do not have a value for the fibroblast 24 hr control sample, we note a significant
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difference between the lower and higher dose at 24 hr, with the percentage of foci positive cells
reducing only slightly 72 hr post exposure for both doses (Refer to Table 6 for exact values).

Table 7. Fold change in 53BP1 Positive cells in each cell layer over time.
OTC
Dose (Gy)
0.1
2
0.1
2
0.1
2
2hr
24 hr
72hr**
Epithelial
3.67
10.54
2.87
13.79
3.61
23.91
Fibroblast
0.69
3.65
ND*
ND*
10
35
* Unable to calculate fold for Fb 24hr samples due to loss of 0 Gy sample.
**control value for Fibroblast & Epithelial 0 Gy samples at 72 hr is 0, so fold value would be expected to be at least these values.

Given in Figure 35 a direct comparison cannot be made between cell types due to different
baseline levels of foci positive cells, we instead compare cell types as a fold over their respective
controls (Table 7). At the earliest 2 hr time point, we observe a greater fold increase for epithelial
cells than for fibroblast cells following both the low and high dose. In fact, the fold change in
epithelial cells at the 0.1 Gy dose was approximately equal to the fold change for the fibroblast
cells following a 2 Gy exposure (3.67 vs. 3.65, respectively). No increase over control was noted
at all for fibroblast cells 2 hr post the lower 0.1 Gy dose. At 24 hr post exposure the fold change
for epithelial cells did not change drastically, but increased again at the 72 hr timepoint, especially
following the high dose (10.54 fold at 2hr and 23.91 at 72 hr). Fibroblast folds could not be
calculated at 24 hr due to loss of the 0 Gy sample, but also increased at the 72 hr timepoint as
compared to the 2 hr timepoint for both the low and high doses. However, an accurate fold value
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at 72 hr is not possible for either cell type as the 0 Gy control value was 0 for each at this timepoint,
so the value presented is approximate (Table 7).

Comparing Doses
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Comparing Tissue Type
C.

D.

1.0

Epithelial

0.8
0.6
0.4
0.2
0.0

2 Gy

Fibroblast

% 2h Damage Remaining

% Damage at 2h Remaining

0.1 Gy

2

24

72

Epithelial

1.0

Fibroblast

0.8
0.6
0.4
0.2
0.0

2

24

72

Hours

Hours

Figure 36. The percentage of 53BP1 foci positive cells remaining relative to
the amount induced at 2hr. Values plotted are the percentage of the 53BP1
foci positive cells at 2hr that remain at 24 and 72 hours post a 0.1 or 2 Gy Fe
600 MeV/n exposure in OTC of epithelial (left) or fibroblast (right) layer.

To assess whether damage in epithelial cells is eliminated at a similar rate following a low
vs. a high dose exposure, we defined the percent of damage induced at 2hr for each dose as 100%
and defined the percentage remaining over time (Figure 36A). The two doses show a similar trend
with most of the damage being resolved in the first 24 hr. Interestingly, following a low dose
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exposure damage appears to be eliminated slightly quicker than damage induced by a higher dose.
For example, 50% of the damage induced by a 0.1 Gy dose is repaired in <24 hours, whereas
following a 2 Gy dose 50% of damage is not resolved until closer to 72 hr.
When plotting a similar graph of the percentage of the damage induced at 2 hr that remains
over time for the fibroblasts, we observed a different pattern (Figure 36B). Here we see an opposite
trend with the low dose showing more damage persistence as compared to the high dose. Damage
induced by the low dose exposure does not resolve as rapidly as damage induced by a higher dose
of radiation in the fibroblast cells. Between 2-24 hours, more damage is repaired for the high dose,
as compared to the low dose, which exhibits a slower repair time. However, at 72 hours, the % of
damage remaining is nearly identical between the high and low doses for the fibroblast cells. The
half time of repair for both doses occurs at the same time of ~72 hours post exposure.
To compare the kinetics of repair between the two cell types following an initial 0.1 Gy
exposure, we over-lay the low dose plots for each cell type (Figure 36C) for the percentage of
the 2 hr damage remaining over time. This comparison clearly shows a more persistent level of
damage in the fibroblast layer as compared to the epithelial layer at the low dose (Figure 36C),
with fibroblast cells showing very little repair (~90% of damage induced at 2 hr still remains) in
first 24 hr, as compared to epithelial cells which have repaired >50% their damage in the first 24
hr. At the latest timepoint analyzed (72hr) there is still a difference, with fibroblast cells having
~50% of their damage remaining, whereas epithelial cells have ~20% of their damage remaining.
Comparing the repair kinetics following 2 Gy irradiation between the cell types as a
percentage of the damage induced at 2 hr still remaining in the OTC (Figure 36D), reveals very
similar repair kinetics between the 2 cell types, unlike what was observed following the lower
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dose. For both cells types 50% of the damage is repaired between 24 and 72 hours following the
higher 2 Gy dose.

Epithelial Layer

Fibroblast Layer

Figure 37. Number of 53BP1 foci per cell based on cell-type, dose and time post exposure. The total
number of cells showing varying numbers of foci per cell in Epithelial and fibroblast cell layers at 2, 24, and
72-hour post 0.1 and 2 Gy Fe 600 MeV/n exposure. Epithelial layer at A) 2, B) 24, and C) 72-hour post
irradiation. Fibroblast layer D) 2, E) 24, and F) 72-hour post irradiation.
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Lastly, to identify if there were differences between the cell types in terms of the number of foci
per cell at each time and dose, we compared this for the epithelial (Figure 37A-C) and fibroblast
(Figure 37D-F) layers of the OTC. As can be observed in the graphs, epithelial cells show a
greater amount of foci per cell at both doses, with both cell types showing a reduction in
numbers with time. A similar pattern of reduction is observed between the cell types; however, at
the low dose we never observe more than 2 foci per cell at any timepoint for fibroblast, but
observe up to 5 foci per cell at the earliest time for epithelial cells (Figure 37A-C vs. 37D-F).
Both cell types show a greater amount of foci per cell at the higher dose as expected, although
fibroblast cells reduce the number of foci per cell more rapidly as compared to the epithelial
layer. Absolute values plotted for Figure 37 are shown in Appendix V for each respective cell
type.
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CHAPTER 4

DISCUSSION
4.1 Thickening of Basal and Suprabasal Layers following Radiation
Analysis of H&E stained sections from mouse organoids revealed a dose and radiation quality
dependent increase in the thickness of what we have labeled the “whole cell layer” of the organoid
(Figure 10). The whole cell layer on the H&E stained images is actually composed of both the
basal and suprabasal layers. A significant increase in thickness of the layer was observed with
dose, with a significant difference exhibited between the sham and 1 Gy Fe600 MeV/n exposed
sample. Organoids exposed to low LET cesium (Cs) also revealed a very slight dose dependent
increase in whole cell layer thickness, although this change was not significant. Given the fact that
low LET radiation is less effective per unit dose, it is possible that with a higher dose, and/or by
scoring an increased number of samples, a significant effect may also have been observed
following the high dose Cs exposure. To better define what may be causing the increased thickness
of the “whole cell layer” additional studies will be needed. Possible explanations for the thickening
of the whole cell layer include 1) a greater number of proliferating basal cells, 2) cells not properly
differentiating as they move up from the basal layer, or 3) an increase in the number of stem cells.
A possible underlying cause for the observed phenomenon may be inflammation and damage
induced by the radiation exposure.
Although we observed significant dose-dependent changes in the whole cell layer there
were no significant changes observed in any of the other measurements. The basal, single cell
layer, length of organoid, width of organoid, and size of the lumen were all not significantly
different based on dose or radiation quality. However, we did observe a slight increase in the total
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length, and less so with the width, of organoids with radiation exposure. Again, this trend was
slightly more prominent with high LET as compared to low LET. Although the increase was only
slight, and did not reach statistical significance, the increases in width and length likely reflect the
dose and radiation quality dependent increase in the thickness of the whole cell layer we observe
following high LET. An increase in the whole cell layer corresponding to dose and radiation
quality, would likely also be observed as an increase in the length and width of the organoid as
well.
A possible future direction would be to investigate if the number of cells making up sublayers change with dose thus resulting in the “thickening” phenotype observed within the whole
cell layer. A Ki67 antibody, which recognizes proliferating cells, could be used to define which
sub layer(s) are actively proliferating. As there is not a good stem cell marker for esophageal tissue,
these studies would at least allow us to define if there are a greater number of proliferating basal
cells, and to define if they are differentiating by using markers specific for the sub-layers.

4.2 Dose-response of MAPK/SAPK Signaling in Mouse Esophageal Organoids in Response
to Fe 600 MeV/n Exposure
These studies were performed to decipher how esophageal tissue, mimicked by using 3D
organoid cultures, may respond uniquely to a low (0.1 Gy) vs. a higher dose (1 Gy) of Fe 600
MeV/u radiation and the role of the TGFb and ATM pathways in this response. In particular, we
wanted to define whether there was cross-talk between the TGFb and ATM pathways and
whether this cross-talk was regulated differently depending on dose. We focused on the stress
pathway as this is a pathway known to be important in responding to environmental exposures,
including radiation.
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Looking at expression patterns in the stress pathway without added inhibitors, we observe
some unique trends with some phospho-proteins 24 hours after exposure. An increase in
expression at the low dose and decrease in expression following the higher dose was observed
with Erk/MAPK, p53 and MEK1. It is also of interest that these same phospho-proteins are
increased to a greater degree at a low 0.1 Gy dose than a higher dose. Although no expression
levels were significantly different between these doses and sham, the pattern of change may
indicate novel dose-dependent regulation of these phospho-proteins. The pattern observed with
Erk/MAPK phosphorylation fits well with previous data showing that low levels of DSBs can
activate ERK pro-survival signaling causing an increase in cell proliferation, whereas higher
levels instead result in ERK dephosphorylation Khalil et al. 2011). The authors of this latter
paper suggested that this shift in pattern is consistent with a dose-dependent switch from a prosurvival state to anti-survival state, although the doses they had considered were higher than
those in the current work. Another study also partially supports our findings as it indicates that
stress-activated kinases are activated by very low doses (0.1 Gy) of ionizing radiation, but
indicates that ERK2 shows a progressive increase in expression with dose, until 3 Gy, at which
point it shows a marginal decline (Narang and Krishna 2004). In the present study we noted a
decrease at a 1 Gy dose, which is below the 3 Gy dose that a decrease in expression was noted in
this previous work. This discrepancy perhaps indicates that tissue type or species may play a role
in activation as Narang and Krishna used rat liver tissue and the present study used human
esophageal cells. One phospho-protein also appeared to show a dose dependent decrease, p38,
indicating its expression may be down-regulated with increasing dose, implying perhaps a
greater role at lower doses vs. higher doses.
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To define the role of ATM, an important key kinase involved in both sensing and
responding to radiation damage (Marechal and Zou 2013), we added ATM inhibitor to the
samples and defined the expression pattern of stress pathway phospho-proteins as compared to
control or dose alone samples (Figure 13). Most phospho-proteins either with no dose or low
doses showed a trend to decrease in expression with ATM inhibition, indicating ATM’s normal
function at no and low doses is to aid in increasing the phosphorylation of these proteins.
Significant decreases were noted in 0Gy irradiated samples with Hsp27 and p38 (Figure 13A)
with ATMi. Also, following a low 0.1 Gy dose p53 expression was significantly decreased
(Figure 13C). This indicates ATM is perhaps specifically important in regulating Hsp27, p38,
and p53 at no and low doses. Fewer phospho-proteins showed a decrease in expression with a
higher dose, only ATF2, Hsp27 and Stat1 (Figure 13F) decreased in expression, with ATF2
showing a significant decrease in expression following a 1 Gy dose +ATM inhibition as
compared to the 1 Gy sample. A dose-dependent decrease in ATF2 expression was also uniquely
observed with ATM inhibition, indicating that ATM is especially important in regulating the
expression of ATF2, and that with increasing radiation exposure ATM plays a larger role. This is
somewhat unexpected as the phospho-site that is captured in this assay is Thr71, not Ser 490/98,
the phospho-site on ATF2 which is known to be regulated by ATM following DNA damage.
Thr71 is phosphorylated to regulate ATF2’s function as a transcription factor (Ouwens et al.
2002) and JNK, p38 or ERK1 are known to phosphorylate it at this particular site. This ATMdependent decrease in ATF2 Thr71 expression; however, could be explained by the fact that
ERK has also been shown to be modulated by the addition of the ATM inhibitor, KU-55933 and
ERK phosphorylation dependent on ATM (Bhoumik et al. 2005). Thus, the effect on ATF2
Thr71 phosphorylation could be indirect and due to ATM’s effect on ERK/MAPK. Further
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studies assaying the Thr71 and Ser 490/98 phospho-sites following radiation in ATM defective
cells would be important to clarify this. Previous work has also suggested that if ATF2 is
phosphorylated on Thr71 it cannot function in its role in DNA damage, as the two sites are
phosphorylated mutually exclusively (Bhoumik et al. 2005). However, in response to severe
and/or sustained stress as caused by ionizing radiation, a portion of nuclear ATF2 is exported
from the nucleus and accumulates in the cytoplasm (Lau and Ronai 2012)(Lau and Ronai
2012)(Lau and Ronai 2012)(Lau and Ronai 2012)(Lau and Ronai 2012)(Lau and Ronai 2012)
(Lau and Ronai 2012), thus it is likely that pools of ATF2 are phosphorylated uniquely on Thr71
vs. Ser490/98 and show differential localization following various dose exposures.
We next defined how added levels of TGFβ may impact the expression of phosphoproteins in the stress pathway at a low vs. higher dose. TGFβ is expressed in tissues following
radiation, both in fibroblast cells within the basement membrane as well as at lower levels in the
epithelial cells themselves (Mauviel 2009, Wang et al. 2012). Thus, results observed are due to
the added TGFβ, in addition to that which may be expressed by these cells following the
radiation exposure. In general, the addition of TGFβ appeared to lower levels of all phosphoproteins independent of dose. Thus, higher levels of TGFβ likely play a role in decreasing the
expression of these stress response proteins. This fits well with previous work noting that TGFβ
is a key regulator of cell proliferation, and in normal tissues its role is to decrease proliferation
(Kurokowa et al. 1987, Kubiczkova et al. 2012).
To gain further insight into the role of TGFβ, we used a specific inhibitor to decrease the
endogenous or exposure-induced level of TGFβ. Following a sham or low dose, we observed
that the majority of all phospho-protein expressions decreased (Figure 15A and D) or remained
unchanged, with the exception of JNK (Figure 15D and E) which increased slightly in sham and
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following a low dose. Based on results using the inhibitor it would seem that TGFβ is important
(at normal levels) in increasing phospho-protein expression levels following no/low doses. This
is in contrast to what we observed with the addition of TGFβ, but it must be emphasized that
there are differing responses to TGFβ depending on the level of its expression. It is likely that at
its normal level in the cell it aids in supporting proliferation with no/low doses, whereas at a
higher level in the cell has an opposite effect. Moving up to a higher dose there are fewer
phospho-proteins showing a decrease in expression, with Erk/MAPk and cJun now showing an
increase, indicating TGFβ would inhibit their expression following a 1 Gy dose.
Of particular interest with the addition of TGFb was the dose-dependent increase in
expression of HSP27, and dose-dependent decrease in expression with TGFb inhibition (Figure
15J), although results were not significant different. These results suggest a role for TGFb in
regulating Hsp27. Our findings are also supported by previous studies in mice noting that the
expression of HSP27 is upregulated in lung tissue and fibroblasts of mice treated with the
radiomimetic, BLM (Wang et al. 2017). They also showed that TGFβ-induced HSP27 expression
and that this was both Smad3- and NFκB-dependent. Lastly, they observed that depleting HSP27
partially inhibited the activation of Smad3 and ERK, indicating a feedback loop between HSP27
and TGFb. Our findings add to this previous work in defining that TGFb modifies HSP27 levels
in a dose-dependent manner.
To better identify if the ATM and TGFβ co-regulate some stress phospho-protein
expressions, we added both ATM and TGFβ inhibitors to the cells and studied response with low
vs. high doses. Similar to the pattern observed following ATM inhibitor alone or TGFβ inhibitor
alone most phospho-proteins with no or low doses showed a trend of decreasing expression.
However, again similar to the single inhibitor patterns following the higher 1 Gy dose there are
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fewer phospho-proteins showing a decrease (compare Figure 16 E & F versus 16A and C).
Also, of interest Hsp27 shows the opposite pattern of increasing with dose when both inhibitors
are added unlike the decrease noted with TGFb inhibitor alone. This unique dose-dependent
pattern would indicate that ATM plays some role in modulating Hsp27 phospho-protein
expression in coordination with TGFb, and that the modulation is dose-dependent.
Another protein showing a dose-dependent expression pattern only in the presence of
both inhibitors was MSK1. With TGFb inhibitor addition MSK1 had not shown an expression
change in the sham or following 1 Gy dose exposure, and only a slight decrease following the
low dose. However, in the presence of both inhibitors, it shows a dose-dependent decrease.
Thus, MSK1 expression also appears to be regulated in a dose-dependent manner by ATM and
TGFb. MSK1 activity is tightly regulated in cells, and its activation requires first
phosphorylation by either ERK1/2 or p38 at other MSK1 sites. Following this, activation of the
c-terminal kinase domain occurs, which then leads to auto phosphorylation of further sites in
MSK1, such as the Ser 212 site (McCoy et al. 2007), the site studied in this work. This would
imply that one or more initial phosphorylation site(s) leading to its autophosphorylation are
controlled in part by both the ATM and TGFb pathways, but further work would be needed to
completely define which sites are coordinately regulated.
To further uncover potential cross talk between the ATM and TGFβ pathways we
focused on unique responses observed in the presence of both inhibitors, that were not observed
in the presence of either inhibitor alone (Figure 17 and Table 1). In this comparison we were
able to identify some phospho-proteins which maybe dually regulated by both pathways
including MEK1 (at no and low dose), JNK (at no and high dose), c-Jun (only in sham), p53 (at
both a low and higher dose), p38 (only at a low dose), MSK1 (at a low and higher dose), and Stat
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1 (only at a low dose). The rest of the phospho-proteins appeared to show similar responses in
terms of expression levels to either one of the single inhibitors alone. A complete overview of all
previous studies noting a role of ATM and /or TGFb in the expression of each of these phosphosites we predict to be uniquely co-regulated is beyond the scope of this paper. However,
centering on one phospho-protein, p53 Ser15, there is evidence in the literature that both ATM and
TGFb regulate this phospho-site, although not specifically in a combined manner. For example,
ROS-dependent mechanisms initiated by TGFb were noted to be essential for p53Ser15
phosphorylation (Samarakoon et al. 2013) and ATM has been shown to be key in localizing p53
to mitotic centrosomes, with phosphorylation at Ser15 playing a critical role (Tritarelli et al.
2004). The findings from this work will provide fodder for subsequent studies investigating the
combined role of both pathways in regulating the expression of these stress pathway phosphoproteins following radiation.
In summary, this work indicates that unique responses are initiated in response to a low
vs. a high dose of radiation, with Erk/MAPK, p53 and MSK1 phospho-sites showing an increase
at a low dose and a decrease at a high dose. Interestingly, p53 has been shown to induce cell
cycle arrest and apoptosis, whereas ERK1/2 to promote cell growth (Suzuki et al. 2001), thus
even phospho-proteins showing a similar regulation with dose may have diverse effects on cells.
This work also clearly indicates that a number of phospho-sites in the stress pathway appear to
be regulated by cross-talk between the ATM and TGFβ pathways, and that different phosphoproteins/sites are regulated uniquely based on dose. Further studies will be needed to dissect the
exact upstream and downstream role of TGFb and ATM, but this work provides important initial
data to further pursue these areas of research.
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4.3 Comparison of SAPK/MAPK Phospho-Protein Response in Human and Mouse
Esophageal Organoids Following Different Radiation Qualities
This study was designed to reveal how the MAPK/SAPK stress pathway phospho-protein
expression differs in esophageal tissue based on dose, radiation quality or species. The work was
also intended to better understand persistent effects by studying samples nine days post exposure.
Stress pathways are induced following environmental effects, including radiation, and
investigating more persistent effects may allow us to better understand changes following
radiation damage that may contribute to cancer development years post exposure.
Mitogen-activated protein kinases (MAPK) are conserved between most species and play
a role in mediating and increasing growth factor signals from the cytoplasm to the nucleus (Dent
et al. 2003). Three major MAPK pathways have been described, including: the extracellular
signal-related kinase (ERK (Dent et al. 2003)); the c-Jun NH2-terminal kinase (JNK) (Raivich
2008); and the p38 MAPK pathways (Sherman et al. 1990) (Figure 5). These pathways are key
in regulating normal cell growth, and are turned on in response to environmental stresses such as
ionizing radiation (IR). The pathways work together to ensure that cell death, growth, and
survival are properly balanced. Typically, studies have shown that JNK and p38 are associated
with apoptosis, whereas the ERK pathway is principally tied to cell proliferation, survival and
the prevention of apoptosis.
There were three major questions we were attempting to address, including whether there
are dose dependent changes, radiation quality or species-specific differences in stress-phosphoprotein expression. This work has revealed some similarities as well as differences, and we will
highlight a few similarities and differences for each topic.
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In comparing dose-dependent similarities or differences, both radiation qualities and
species revealed a significant and dramatic increase in c-Jun phosphorylation following the low
0.1 Gy dose, and a lower increase following a higher dose of 1 Gy, indicating a decrease in the
activity of this protein at a higher dose (compare Figure 18A/19A and 18E/19E).
Phosphorylation of c-Jun at Ser73 has typically been linked to enhanced transcriptional activity
(Raivich 2008) with JNK being the primary kinase responsible for this activation. However,
other MAPKs, including p38 and Erk/MAPK have also been shown to regulate c-Jun
phosphorylation depending on the cellular processes, with the specific kinase likely dependent
on cell type and/or the cellular context. However, following a low dose of high LET exposure
neither JNK, p38 or Erk/MAPK were similarly elevated at this timepoint, and in fact showed
lower levels as compared to control, with Erk/MAPK being significantly lower. Given we have
only defined the expression nine days post exposure, just a window in time, we are unable to
discern if perhaps one of these upstream kinases was elevated at an earlier timepoint and then
subsequently down regulated, perhaps in a feedback type of mechanism. Studies have shown that
c-Jun Ser73 phosphorylation can be stimulated by proinflammatory factors, and that
accumulation of these proinflammatory factors modulate c-Jun phosphorylation and activation.
Although previous studies have also shown c-Jun to be regulated by ionizing radiation, most
studies to date have not centered on very low doses as we have in this work, and also typically
define total c-Jun levels, rather than specific activation at this phospho-site. For example, c-Jun
RNA levels were shown to exhibit a dose dependent increase in HL-60 promyelocytic leukemia
cells, with levels being virtually non-existent at the lowest dose of 2 Gy on a Northern blot
(Sherman et al. 1990). They also noted a dose rate-dependent difference, whereby lowering the
dose rate increased protein levels, but the authors were unclear as to the molecular mechanism
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underlying this finding. Thus, our finding showing c-Jun to be significantly increased at such a
low dose, but not at a higher 1 Gy dose, both with high and low LET radiation, is unique and
requires further investigation.
Another dose-specific response observed following Fe 600 MeV/n exposure is the
increase in expression at the high dose and decrease in expression at the low dose of Erk/MAPK,
as compared to sham (Figure 18K). Thus, an opposite expression pattern is observed with dose.
Other work has also shown a complex association between dose and phosphorylation. Very low
doses of X-ray between 2-5 cGy were shown to stimulate proliferation of normal human diploid
cells, whereas higher doses (>1 Gy) caused a decrease in Erk/MAPK phosphorylation (Suzuki et
al. 2001). Additional work, in mesenchymal stem cells isolated from rats and cultured in vitro,
has shown phosphorylated ERK1/2 to be significantly increased with radiation exposure peaking
~6 h after exposure to 0.75 cGy X-rays (Liang et al. 2011). The latter study noted a dosedependent increase from 0.2 to 0.75 cGy and decrease at 1 cGy. These doses are significantly
lower than what we have used in the current work, but suggest that different dose ranges have
specific multi-modal regulation, likely also differing depending on the time post exposure.
It is important, as most radiation studies have been performed using low LET radiation,
and radiotherapy is moving to conformal types of therapy such as carbon ion, to discern if high
LET radiation causes unique stress pathway expression patterns. In addition, it is likely that
responses differ depending on the dose. Some responses more specific to high LET include the
increase in expression of HSP27 and p53 following the higher 1 Gy dose in human cells. Mouse
cells also exhibit a difference between radiation qualities with p38 and Erk/MAPK significantly
elevated following a 1 Gy dose of Fe but not Cs. Directly comparing expression levels for each
radiation qualities as a fold over control reveals human cells to have a greater number of
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phospho-proteins showing higher levels of expression following high LET for both doses.
Whereas mouse cells had a greater number of phospho-proteins showing higher expression
following the low LET radiation exposure, although more so following the low as opposed to the
high dose. Given high LET ions are more biologically effective per unit dose, one might expect
less expression induced at the low dose as at this dose not all of the cells are transversed by the
radiation (~60%). However, chronic ROS and bystander effects could cause additional effects in
neighboring cells. Our results imply humans elicit a more persistent response to high LET, even
at low doses, as compared to low LET. Whereas mouse cells at a low dose elicit more of a
response with low LET exposure, and only at a high dose does Fe irradiation cause a more
persistent and larger effect.
Another observation following both Fe and Cs irradiation is that in mice nearly all the
phospho-proteins remain elevated, especially following the low 0.1 Gy dose (Figure 20A, B and
Figure 21A, B). This result appears to suggest (An et al. 2013)absent in murine cells, partially
functional in chicken cells and fully functional in human cells. However, survival curves did not
appear to relate to levels of SSB repair. Additionally, potentially lethal damage (PLD) repair was
more proficient in both human and chicken cells as compared to murine cells, which may relate
in part to the differing sensitivities observed. What appears evident from our results is that there
is a difference between the expression of phospho-proteins following radiation between mouse
and humans, and in some cases opposite effects are observed. In addition, Erk/MAPK is also
uniquely regulated in mouse vs. humans, being significantly elevated in humans and unchanged
in mice. However, there are some commonalities, for example ATF2, STAT1, and c-Jun all
show an increase in expression in both species following the low dose exposure. Another major
difference between the species is the lack of the HSP27 phospho-site in mouse, suggesting
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perhaps less importance in dealing with environmental exposures. In general, there appear to be
some conserved responses between the species, but for most phospho-proteins unique responses
are observed and this fact should be of concern in extrapolating results from mouse to human.
In summary, some unique and conserved findings were observed comparing radiation
quality and species SAPK/MAPK phospho-protein expression levels nine days post a low vs.
high dose (Table 8). c-Jun was unique in being increased in nearly all situations, both at the low
and high dose, with both radiation qualities and within both species. Other increases or decreases
appear to be specific to either the species or radiation quality. Thus, caution should be used in
generalizing these results either between radiation qualities or between mouse and human results.
This study also points out the importance of performing time course studies to better define
relationships between signaling nodes. However, this study provides preliminary data on
persistent levels of stress pathway activation based on dose, radiation-quality, and species to
further investigate in a more comprehensive manner in the future.
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Table 8. Phospho-proteins showing significant increases or decreases depending on
species, radiation quality or dose. Compilation of phospho-protein expressions that were
either significantly increased or decreased from sham, p<0.05 for each species and radiation
quality.
Increase
0.1 Gy
1 Gy
Fe 600
c-Jun
ATF2, p53, Erk/MAPK
Cs
c-Jun
JNK
M-Fe
ATF2, p53, MEK1, JNK
p53, MEK1, MSK1, p38, Erk/MAPK, JNK
M-Cs
c-Jun, ATF2, p53, MEK1, MSK1
ATF2, p53, MEK1, MSK1, JNK
Decrease
Fe 600
Cs
M-Fe 600
M-Cs

0.1 Gy
Erk/MAPK
Erk/MAPk
None
None

1 Gy
None
JNK
None
None

Abbreviations M=mouse

4.4 Radiation Quality and Dose-dependent Effects on Persistence of gH2AX in Mouse
Esophageal Organoids

The purpose of the radiation quality and dose-dependent effects on Persistence of gH2AX in
Mouse Esophageal Organoids study was to define whether different radiation qualities cause
unique and persistent damage in exposed esophageal tissue. Radiation-induced foci (RIF) were
quantified using gH2AX, a marker typically associated with double strand breaks (DSB).
Observing higher levels of gH2AX nine days following a particular radiation quality will allow us
to speculate if a given radiation quality has a greater propensity to induce genomic instability in
exposed esophageal tissue. Most studies to date have noted that DNA damage foci are typically
resolved within hours of the exposure at the doses used in this study, with slightly more remaining
up to 24 hr following the higher 1 Gy dose (Mariotti et al. 2013). However, foci evident at many
days post exposure have also been linked to Reactive oxygen species (ROS). ROS is induced
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immediately following radiation, but is thought to be further induced due to unrepaired damage,
which stimulates additional ROS levels, and oxidative stress within the cells. This increase in
ROS and oxidative stress in turn result in even more DSBs (Sridharan et al. 2015). It is thought
that this chronic ROS may lead to a greater susceptibility to cancer at much later times (years) post
exposure. In these studies organoids were seeded a day prior to radiation and fixed nine days post
exposure when organoids were fully formed. Thus, only the initial parental cells used to seed the
organoids were damaged by the radiation and yet presumably a number of the daughter cells have
acquired gH2AX foci during the nine-day period following radiation. Given only the initially
seeded cells were directly irradiated, the finding of a much greater proportion of cells exhibiting
foci suggests these directly irradiated cells must somehow cause gH2AX foci in the daughter cells.
A possible mechanism for this could be through ROS emitted into the medium by the directly
irradiated cells. Alternatively, Ricoul et al. has shown that persistent gH2AX foci can be observed
at the sites of misrepaired lesions (Ricoul et al. 2019). This would suggest that cells containing
chromosome aberrations were transferred to the daughter cells, again resulting in an overall
persistent elevation in gH2AX foci within the esophageal organoid tissue, generations post the
exposure.
Surprisingly, although it would be expected that Fe 600 MeV/n induces more damage per
Gy, and thus perhaps have more persistent foci, our work shows lower levels of persistent foci at
each dose for Fe 600 MeV/n as compared to cesium (Figure 26). At the low dose this could be
explained by the fact that only ~60% of the initially seeded cells are transversed by a particle,
whereas at the higher 1 Gy dose all the seeded cells would be expected to have been hit during
the initial exposure. Thus, the rationale could not explain the lower levels observed at a higher
dose of Fe 600 MeV/n as the exposure would be to all cells, similar to low LET exposure. Given
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the greater effectiveness of high LET ions in producing more complex damage per unit dose,
which is more difficult to repair (Niemantsverdriet et al. 2012), a possible explanation for the
lowered levels of gH2AX foci positive cells following Fe ion exposure as compared to cesium is
that there are fewer surviving cells left to divide and form the organoids, which are then scored
for foci positive cells 9 days post exposure. However, another by Chevalier et al.study
comparing radiation quality effects using 3D organoid cultures did not see similar radiation
quality effects (2019). Work done using a 3D chondrosarcoma model show that high-LET
radiation (Carbon 95 MeV/n, 2 Gy) produced higher and more persistent foci as compared to
low-LET (X-ray) exposure (Chevalier et al. 2019). Obviously, these results are not consistent
with our findings, but the difference in results could be explained by a number of divergences
between these studies. The studies differed in: tissue type, final time point, dose, method of
gH2AX detection, and type of high LET radiation exposure. Thus, additional time course studies
using our model defining gH2AX foci and the level of apoptosis would be needed to determine
whether our speculation is correct.
We speculate the results suggest that Fe ions may induce more deadly insults leading to
the elimination of cells in actively growing cultures, whereas cesium exposure may allow cells to
survive, due to the lower level of damage, resulting in gnomically unstable daughter cells. Whether
the ability to survive leads to a greater risk of cancer in the long term, is speculative, but further
time course 3D tissue and animal studies may help to resolve this.

4.5 Radiation Quality and Dose-dependent Effects on Persistence of 53BP1 Foci in Mouse
Esophageal Organoids
This study was designed to determine if there are radiation quality and dose-dependent
differences in the sensitivity of esophageal tissue, using 53BP1 foci as a marker of damage.
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Mouse organoid cultures were exposed to a high LET radiation, Fe600 MeV/n, and a low LET
radiation Cesium, at either a low 0.1 Gy or higher 1 Gy dose. The three-dimensional (3D) mouse
esophageal organoid model was used to mimic actual esophageal tissue and fixed nine days post
irradiation to investigate persistent effects. Organoids were seeded a day prior to irradiation, to
then define the effects of irradiation on a growing tissue. Organoids were fixed and sectioned
after 10 days of growth and stained for 53BP1 foci. 53BP1 is typically used at early times post
exposure as a marker of DNA double strand breaks. Conversely, at longer times post exposure
these foci may also represent senescence-associated heterochromatin foci (SAHF). Senescent
cells can be induced by ionizing radiation and have been shown to stain positively for 53BP1
foci which co-localize with gH2AX foci (Minieri et al. 2015).
In comparing the number of 53BP1 positive cells per organoid between radiation
qualities we observe slightly higher numbers following Fe ion exposure than for cesium at the
lower dose. Whereas at the higher dose levels of foci are fairly similar (Figure 28). As baseline
levels were much higher in the cesium irradiated cells, we graphed each endpoint as a fold over
control. In doing so we observe Fe ion exposed organoids to show greater levels of cells
containing foci and pan-staining at both doses (Figure 30). Compared to the majority of foci
studies which have been done previously, nine days post exposure is a fairly long time period
after radiation to quantify foci, thus there are no other 3D studies that we are aware of that we
can directly compare to at this timepoint. However, studies have shown Fe ions to be typically
more biologically effective and produce more lasting damage (Wang et al. 2012), which would
agree with our findings.
Although no other esophageal 3D tissue culture models have studied radiation quality
effects, skin has a fairly similar structure and work has been done comparing radiation quality
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differences in 3D skin models up to 72 hr post exposure (von Neubeck et al. 2015). This work
revealed that radiation quality differences were more important in predicting detrimental
biological effects (proliferation and differentiation) than was dose (von Neubeck et al. 2015).
However, a number of differences exist between these studies including: a different type of
radiation exposure, different cell type, different endpoints and time point. It is of interest that
induced proliferation and differentiation was observed to a greater degree specifically in high
LET exposed samples.
Other researchers have attempted to better understand what persistent damage in cells
may correspond to. For example, standard monocultures were used to investigate persistent
DSBs up to a month post exposure. Nine different cell lines were used by Dikomey et al.to detail
the relationship between radiosensitivity and persistent double-strand breaks (as measured by
pulse field) (1998). This work revealed residual DSB to be a fairly good predictor of
radiosensitivity (Dikomey et al. 1998). If the residual foci measured in our assay accurately
reflect unrepaired DSB 9 days post exposure, our results would suggest that Fe 600 MeV/u
exposure is more detrimental to esophageal tissues than is Cs exposure. Unfortunately,
confirmation of DSB by another method would be needed to verify this.
It is also possible that the foci mark senescent cells, although typical doses that result in
senescent cells are much higher (>6 Gy X-ray). In any respect, levels of unrepairable DSBs have
been used to identify individuals at greater risk for developing the adverse effects associated with
radiotherapy (Noda 2018). Thus, whatever the underlying reason for the higher levels of
persistent foci, we might speculate that our results may indicate that esophageal tissue is
radiosensitive and that Fe is more damaging than Cs to this tissue. Comparison with other 3D
tissue models would be needed to confirm esophageal tissues’ relative radiosensitivity.
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It is uncertain what 53BP1 pan-stained cells represent at these late time points, as typically total
53BP1 is found throughout the cell and just relocalizes to DSB after damage. However, panstained gH2AX cells have been noted and associated with replication stress (Moeglin et al. 2019)
and although 53BP1 has not been studied in this context, it has been shown in normal cells to colocalize with gH2AX during S phase (Harding and Bristow 2012). Thus, these cells could be
defining cells in S phase and possibly cells experiencing some replication stress as well. Given
the dosed samples show more elevated levels, it may reflect replication stress. In addition, work
has shown that low and high-LET radiation increase ROS levels, but the induction is
independent of radiation quality and dose (Werner et al. 2014), which is what we appear to see
for the 53BP1 pan staining phenotype. It is of interest that for cesium the lower dose appears to
experience far greater effects, and the reason for this is uncertain. Further studies would be
needed to define if ROS levels and oxidative stress were responsible for the elevated pan-stained
53BP1 signal in the esophageal organoids.
In summary, this work reveals a radiation quality difference in persistent 53BP1 foci within
the esophageal tissue, indicating Fe600 MeV/n to be more damaging than cesium. It also hints
toward some non-radiation quality dependent increases in ROS that may lead to increased
oxidative stress and damage in long-term radiation-exposed esophageal tissue. Future more
detailed and multi-endpoint (senescence, ROS levels, cell cycle) time course studies would be
needed to confirm these results.

4.6 gH2AX Kinetics in Human Esophageal Organotypic Cultures Following
Fe 600 MeV/n Exposure

gH2AX radiation induced foci (RIF) have been used in a large number of studies to define levels
of double strand breaks (DSB) induced post exposures and to understand the kinetics of repair
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(Rogakou et al. 1998). gH2AX, at least at early times post repair have been shown to provide a
fairly good correlation to the number of DSBs (Lobrich et al. 2010). In this study we strove to
define the sensitivity of esophageal tissue to Fe 600 MeV/n exposure by quantifying gH2AX foci
at various times post exposure using a human esophageal organotypic model and establishing the
kinetics of induction and repair. Both a low, 0.1 Gy, and a higher, 2 Gy, dose were used and
samples collected at 2, 24 and 72 hr post exposure. Human esophageal organotypic 3D cultures
were used in an attempt to more closely mimic actual human esophageal tissue. As esophageal
organotypic cultures contain both fibroblast and epithelial cells this also allows foci kinetics for
the two cell types to be defined as well.
Predictably, a dose-dependent increase in gH2AX foci was observed at 2 hr for both cell
types, however, differences were not significant except in the fibroblast cells which showed
significant differences between the sham and the 2 Gy samples at all timepoints (Figure 31). It is
evident from the comparison between the cell types that epithelial cells appear to induce fewer foci
positive cells as compared to fibroblasts, but one caveat to the analysis was the much lower total
numbers of cells that could be scored in the fibroblast layer (Table 5), as images did not include
much of this layer, which likely limits the robustness of the findings. Larger studies focusing
specifically on the underlying fibroblast layer would be needed to verify the differences observed
between these cell types.
It is difficult to directly compare the kinetics of removal we observed with other studies as
typically they present foci per cell or total fluorescence per cell, which we did not define in this
work. In addition, the majority of other studies have not been done using 3D tissue models. But in
comparing results from another study looking at the rate of foci loss per cell over time in fibroblasts
following X-ray, ~25% of the foci present at 2 hr are remaining at 24 hr in a study done by Lobrich
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et al. (Lobrich et al. 2010). This is similar to what we observed at 24 hr for the epithelial cells, but
not the fibroblast cells. Besides the fewer cells scored in the fibroblast layer, this difference could
also be due to a number of other reasons. For example, it is possible that high LET, as opposed to
low LET X-ray, causes more of a delay in damage resolution in fibroblasts. This is suggested in
work by Sridharan et al., which measured gH2AX intensity per cell by flow cytometry in
fibroblasts, and revealed a maximal induction of gH2AX foci at 2 hr post exposure following Fe
ion exposure whereas following X-ray maximum levels were noted at the earliest timepoint
measured, 0.5 hr (2020). However, if this was the case one would expect foci positive cells to
decrease following 2 hr rather than at 72 hr post exposure as was observed. Therefore, the
difference in our study with previous work may have to do more with our tissues being exposed in
a 3D rather than a 2D context.
Previous work studying gH2AX kinetics in human mammary epithelial cells, in both a
2D and 3D context, noted that if the cells were not proliferating, foci were still present 72 hr post
exposure (Groesser et al. 2011). However, if they were proliferating, either in 2D or 3D context,
they decreased to control levels by 24 to 48 hours. Typically, in the fibroblast layer there is no
further proliferation occurring following the OTC seeding. However, epithelial cells may
continue to proliferate, and based on this previous work, this would allow the cells to resolve
damages.
An especially unexpected and peculiar finding of this study was the lowered levels of foci
positive cells at 24 hr and increase at 72 hr observed in the epithelial cells. Possible explanations
for this finding include, an increase in foci positive cells due to misrepair of the induced
damages, which might show up at this later time point, particularly at the higher dose. This is
supported by a study revealing that gH2AX foci are present at the sites of misrepair and sites of
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chromosome aberrations (Ricoul et al. 2019). Or alternatively, unresolved damage has been
shown to increase ROS, which in turn increases DNA damage and this could be specifically
occurring more prominently in the epithelial cell layer (Sridharan et al. 2015). Further time
course studies defining levels of misrepair and /or ROS levels in the OTC cultures would be
needed to resolve this.
In conclusion, the study provides evidence of a cell type, but not dose-dependent,
difference in resolution of gH2AX foci in a 3D tissue context. In addition, based on prior gH2AX
work (Mariotti et al. 2013) following low LET radiation more persistent effects are suggested
following high LET, although a direct comparison in this model system would be needed to
confirm this. Overall, the persistent levels of foci positive cells at late times in the esophageal
OTC may indicate severe consequences such as chromosome aberrations, or genomic instability,
and suggest Fe 600 MeV/u exposure may have lasting ramifications on this tissue in vivo and
increase the potential of cancer development.

4.7 53BP1 Kinetics in Human Esophageal Organotypic Cultures Following Fe 600 MeV/n
Exposure

Epithelial and fibroblast cells within the OTC were scored separately to define whether
differences in radiation sensitivity exist between the two cell types even when exposed as part of
the same 3D tissue construct. These studies reveal that different cell types, even within the same
tissue, can show unique DNA damage kinetics following radiation exposure (Figure 36). For
example, 2 hr post exposure fibroblast cells fail to show an increase over control for the low dose
exposure and exhibit only a ~3.6-fold increase following a larger 2 Gy exposure. This is very
different from the epithelial cells which show a 3.6-fold increase over controls at the low dose and
a ~10.5-fold increase following the higher dose (Table 7).
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However, the differences between the cell types also appear to be dose specific. Fibroblast
cells exhibit a lower number of foci positive cells at 2 hr and a slower resolution of damage
following the low dose exposure, which is different from what is observed following the higher 2
Gy dose (Figure 36C vs. 36D). This pattern of response is opposite from what is observed in
epithelial cells, where a faster repair following the low dose is detected. However, following the
higher dose, we observe a more similar response between the cell types (Figure 36D). It may make
sense following a high dose for the repair to take longer due to greater numbers of complex double
strand breaks being a larger component of the total damage induced. However, if this is the case
then only the epithelial cells exhibit the expected pattern whereby damage is repaired more rapidly
following a lower vs. a higher dose.
Our findings indicate that fibroblast cells fail to induce a very robust response at low
doses yet are slow to repair as compared to epithelial cells (Figure 36A vs. 36B). A similar
delayed repair response for fibroblast was observed by Lobrich and colleagues using primary
human fibroblasts cells (Rothkamm and Lobrich 2003, Grudzenski et al. 2010). They observed
that fibroblast cells were able to repair a single DSB proficiently if the break was induced with
doses between 40–80 mGy (0.04-0.08 Gy), yet failed to repair damage induced by a very low 10
mGy (0.01 Gy) dose, and that damage induced by this dose remained unrepaired for up 72 hours
post irradiation (Rothkamm and Lobrich 2003, Grudzenski et al. 2010). Thus, although these
researchers did observe a delay following a low vs. a higher dose, their low dose was much
lower than ours. Based on their studies done using 2D monocultures we would have expected our
low dose damage in fibroblasts to repair with normal kinetics, as the low dose we used (0.1 Gy)
is similar to their 80 mGy dose, which did show efficient repair. In addition, the rationale
provided for the delayed repair does not fit our observation, as they note that a threshold level of
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damage is needed to activate the repair mechanisms and that below this level cells are unable to
repair DSBs (Rothkamm and Lobrich 2003). However, it is possible that there is a dosedependent resolution of repair occurring within the dose range we used as well, with repair being
slower following the low vs. the higher dose. In addition, a number of differences exist between
our study the Rothkamm and Lobrich., including our use of high LET radiation and exposure in
3D vs. 2D (2003). Further 3D OTC studies including more robust numbers of fibroblast cells
would be needed to confirm our findings.
Another possible explanation for the unique difference between cell types following the
low vs. higher dose exposure is perhaps differences in the cells response to bystander induced
damages. Following the low Fe600 MeV/n dose, only 35% of cells are hit, with an average hit per
cell of 0.4. Whereas following a higher 2 Gy dose 100% of cells are hit, with an average hit per
cell of 8.5. Given the cell sizes for each cell type are approximately the same (117 μm2 and 120
μm2 ,respectively), the difference observed between cell types could not be attributed to differences
in the fraction of hit cells. Bystander effects may be more prevalent at a lower dose, given 65% of
the cells are only exposed to bystander effects and not to any direct radiation exposure. Thus, we
might speculate that the DNA damage induced by bystander damage is less readily repaired by
fibroblasts. A follow up study to identify if bystander damages are more difficult for fibroblast
cells to repair could be performed to determine if this speculation has any value.
In conclusion, the study provides novel evidence of a cell type and dose-dependent
differences in the induction and resolution of damage, even when different cell types are exposed
as part of the same 3D organotypic culture. In companion studies future work will define the
kinetics of gH2AX resolution in the OTC to determine if similar differences exist for this phospho-

105

protein based on cell type or dose, to help us confirm the unique dose-dependent resolution of
repair we observe in the fibroblast layer of the OTC with 53BP1 foci.
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CHAPTER 5

CONCLUSION AND FUTURE DIRECTIONS
Radiation-induced esophageal cancer is a deadly and unfortunate possible outcome of
radiotherapy. Understanding some of the factors responsible for the sensitivity of this tissue may
aid in providing strategies to prevent this type of cancer. In this study we used two esophageal
3D model systems to define radiation quality and dose dependent changes in tissue morphology,
MAPK/SAPK phospho-protein expression, crosstalk between the TGFβ and ATM pathways, and
DNA damage and repair kinetics following irradiation as a means to better understand
esophageal tissue sensitivity.
An initial observation suggesting a sensitivity of this tissue to radiation was the change in
the esophageal tissue morphology. Our studies using mouse 3D organoids revealed
morphological changes in esophageal tissue exhibiting both a radiation quality and dose
dependence. Significant changes were noted only following the highest 1 Gy dose, and only with
high LET Fe 600 MeV/u exposure. Although a trend of increasing thickness of tissue with dose
was also observed following cesium exposure, the changes were not significant. The underlying
etiology of the change in tissue thickness is uncertain; however, previous studies using other 3D
tissue models may give us a hint as to the underlying cause(s). For example, using a human skin
3D OTC model, Von Neubeck et al., also noted an increase in the thickness of certain layers of
the skin following high LET exposure and corresponding changes in the skin’s proliferation and
the differentiation process (von Neubeck et al. 2015). However, the researchers tested a number
of high LET particles and found tissue changes to be complex and differ depending on the time
point of analysis and the LET of the radiation, with LET rather than the dose delivered playing a
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more major role in the effects. These results would suggest that proliferation or improper
differentiation may underlie the morphological changes in the esophageal tissue that we
observed. Future studies using specific antibodies to detect changes in proliferation and to
identify specific cell layer within the tissues would be needed to confirm this. This work would
also suggest that high LET radiation when used for radiotherapy should be used with caution as
non-target effects could be more damaging to the esophageal tissue than low LET exposures.
Cellular adaptations due to radiation exposure likely underlie the tissue morphological
changes observed. The MAPK/SAPK signaling pathway is an important pathway activated by
radiation, which impacts the growth and differentiation of tissues. Therefore, we studied
MAPK/SAPK signaling following high LET Fe 600 MeV/n exposure at both an early (24hr) and
late timepoint (9 days) in human and mouse organoids (respectively) to provide additional
information to aid in understanding the esophageal tissue’s radiosensitivity.
One key dose-dependent difference observed in the MAPK/SAPK stress pathway
expression was an increase in expression of Erk/MAPK, p53 and MEK1 following a low dose,
and a decreased expression of this same set of phospho-proteins following a high dose. This
unique Erk/MAPK phosphorylation profile has been observed previously in human glioma cells,
indicating that low levels of DSBs can activate ERK pro-survival signaling, whereas higher
levels instead result in ERK dephosphorylation (Khalil et al. 2011). The latter study also
observed that Erk/MAPK phosphorylation corresponded with increased levels of double-strand
breaks and cellular proliferation. In contrast with this finding are our radiation dose-dependent
tissue morphology changes, as we would expect the lower dose of Fe 600 MeV/n exposure
resulted in an increased tissue thickness as compared to the higher dose, given it provided more
Erk/MAPK phospho-signaling 24 hr post exposure. However, Khalil et al used restriction
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enzymes to induce DSB rather than radiation and other temporal, radiation quality, cell type
differences between our work and theirs may explain the conflicting results observed (2011). In
addition, the tissue morphology difference we noted was observed in mouse, rather than human
esophageal organoid tissue, making a direct comparison between the thickening of the tissue and
phospho-signaling patterns at 24 hr post damage not possible due to the species difference.
However, mouse organoids were used in our study investigating MAPK/SAPK phosphoprotein signaling patterns at a later nine days-post exposure timepoint. In this work we do reveal
Fe 600 MeV/u to induce higher levels of Erk/MAPK expression, similar to the study by Khalil et
al., and that higher doses of exposure result in a significant increase in Erk/MAPK
phosphorylation. This same finding is also observed in human esophageal organoid tissue at this
same timepoint (Figure 18 and 20). Thus, the results nine days following 1 Gy Fe 600 MeV/n
support higher levels of damage initiating greater levels of Erk/MAPK signaling, cellular
proliferation and resulting in the esophageal tissue thickening that we observed. Other phosphoproteins such as p38, JNK, and p53 showed a dose-dependent increase in mouse esophageal
samples nine days post Fe 600 MeV/n irradiation and could also be important in the tissue changes
observed post radiation. Especially, given p53’s is importance in responding to DNA damage
(Williams and Schumacher 2016) and p38’s, similar to Erk/MAPK, role in stem cell proliferation
and cell differentiation (McConnell et al. 2016). Whether esophageal tissue is more sensitive to
these radiation-induced cellular effects as compared to other tissues is an important question and
would require additional studies comparing different cell type 3D tissue models to resolve.
Another important question we strove to understand by probing the ERK/MAPK
signaling pathway expression patterns, was the importance of two major radiation response
proteins, TGFb and ATM. Using protein-specific inhibitors to each of these proteins and
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defining phospho-protein expression patterns at the early 24 hr time point, we observed
differences that allow us to speculate on potential cross-talk between these pathways in response
to radiation. We noted unique patterns of expression when organoids were exposed to both
protein inhibitors, that were different from the expression patterns exhibited with either single
inhibitor alone. This would imply some crosstalk between the ATM and TGFb pathways in
regulating specific phospho-protein expression. The evidence of cross talk was also in some
cases dependent on dose, being observed only in the sham, low or high dose exposed samples
(Table 1). For example, evidence for cross-talk between the pathways is only noted for JNK
following a high dose and only noted for MEK1 following a low dose. Yet, there were some
phospho-proteins, such as p53 and MSK1 that revealed cross-talk between the pathways at both
the low and high dose. Links between these pathways and p53 have been noted by others, for
example TGFb has been shown to indirectly stabilize p53, and ATM phosphorylates p53
following damage (Appella and Anderson 2001, Liu et al. 2017). Of particular importance is the
fact that crosstalk between TGF-β signaling and p53 is thought to play a critical role in cancer
progression (Elston and Inman 2012). Further work is needed to define whether the crosstalk we
observed in esophageal tissue is more aberrantly affected following radiation exposure as
compared to other tissue types, or differs based on radiation quality, perhaps impacting
esophageal cancer risk. Nonetheless, these findings provide key areas to follow up on in future
studies.
DNA damage is a natural outcome of radiation exposure and the kinetics of their
induction/resolution have been monitored using antibodies against phospho-proteins that
accumulate at the sites of DSBs to provide information regarding the cell’s radiation sensitivity
and susceptibility to cancer (Willers et al. 2015). In this study, we exposed two different types of
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3D esophageal cellular models to different radiation qualities to define differences in radiation
quality and dose. In addition, we were able to investigate species specific differences as one model
system, the OTC, used human cells, and esophageal organoids were produced using mouse cells.
Furthermore, the OTC is made using both esophageal fibroblast and epithelial cells which allowed
us to examine cell specific differences as well.
Focusing first on foci kinetics at early times in the OTC model following Fe600 MeV/n
exposure, as expected, higher doses of both radiation qualities resulted in higher levels of damage
in both cell types. In addition, as time proceeded levels continued to reduce, with similar overall
patterns observed in terms of foci resolution for both gH2AX and 53BP1 (a phospho-protein
present in the chromatin and one recruited to the damage, respectively). However, when comparing
the patterns in greater detail some differences are noted between cell types and between the kinetics
for each phospho-protein. For example, levels of gH2AX tended to be lower for both cell types in
the first 24 hr, yet higher as compared to 53BP1 foci levels at the later 72 hr timepoint.
A cell type dependent difference common to both DSB markers was that fibroblast cells
tended to induce greater numbers of foci positive cells per Gy, which took longer to resolve as
compared to epithelial cells. This was especially evident following the lower 0.1 Gy dose, as foci
numbers remained virtually unchanged over a 72-h period, but reduced to some degree during this
period following the higher dose. In contrast, our work revealed epithelial cells to repair damage
from the higher 2 Gy dose more slowly than the lower 0.1 Gy dose when comparing foci resolution
over time. A similar finding to ours was observed by Rothkamm and Lobrich using fibroblast
monocultures, which showed that DSBs induced by a low dose of X-ray took longer to resolve
(Rothkamm and Lobrich 2003), but a much lower dose (1 mGy) was used in this study. Whether
the differences in induction and resolution of the foci between the cell types at earlier times plays
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a role in a greater propensity for cancer years later is uncertain, but given epithelial cells are more
prone to cancer, and yet we appear to note a greater sensitivity in fibroblast cells, we would deduce
that early kinetics do not relate to cancer predisposition. In fact, studies have shown that persistent
foci in cells at much later time are more relevant in understanding a tissue’s propensity to develop
cancer (Bonner et al. 2008).
Assessing DNA damage foci kinetics at much later points revealed differences between
radiation qualities and the kinetics of each DNA DSB marker. Mouse esophageal organoids were
exposed to either cesium or Fe 600 MeV/n and fixed nine days later to define DNA damage foci
kinetics. Both gH2AX and 53BP1 kinetics were studied, similar to our work done at 24 hr with
human organoids. This work revealed a clear dose response following cesium irradiation with a
greater yield of gH2AX foci and fewer 53BP1 foci induced per unit dose of cesium exposure. In
contrast following Fe 600 MeV/n exposure, the opposite was true, more 53BP1 foci as compared
to gH2AX foci were observed per unit dose. It is unclear why differences exist between the
radiation qualities in terms of the prevalence of a particular DSB marker. However, what is
consistent is that higher levels of residual foci are present with exposure to higher doses, thus likely
suggesting a 1 Gy dose, as used in this study, a dose higher than likely to occur in non-target tissue
during radiotherapy, may lead to changes that increase cancer risk. More studies are needed to
define the threshold dose for residual foci and to directly compare repair kinetics in different 3D
cell type models, within the same species, to define the relative radiation sensitivity of esophageal
tissue to and understand how this may relate to cancer risk.
In summary, this thesis provides evidence for radiation quality, cell type and species
dependent radiation effects in esophageal tissue. It also provides evidence for a greater
effectiveness of high LET exposure as compared to cesium but reveals this to be dose-dependent.
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Additional time course and dose studies are needed using multiple tissue-type 3D models to better
define the relative sensitivity of esophageal tissue and to understand molecular mechanisms
leading to the increased radiation sensitivity and propensity to develop cancer.
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APPENDICES
APPENDIX I
FOLD CHANGE OVER CONTROL FOR FIGURES 12-17

Appendix Table 1. Luminex 24 hr, Fold increase over controls for each phospho-protein
with dose
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APPENDIX II
FOLD CHANGE OVER CONTROL FOR FIGURES 18-21

Calculated fold changes for MAPK/SAPK phospho-protein expression levels for human
and mouse esophageal organoid samples as compared to sham following Fe 600 MeV/n and
cesium exposures.
The expression of each phospho-protein was calculated as a fold over the sham for each sample.
The folds were then used to determine which phospho-proteins had a similar trend in their
induction, either increasing (>1.2 fold), decreasing (<0.8 fold) or staying approximately the same
as control expression (1.1 to 0.9). These fold calculations were used to define what phosphoproteins to graph together for Figures 18-21.
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APPENDIX III
RADIATION QUALITY FOLD CHANGES FOR FIGURE 22-23

Radiation Quality fold changes for human and Mouse Esophageal samples. Fold change
comparing Fe600 induced expression to Cs expression was calculated for each species based on
their respective controls. These calculated folds were used to define which graphs to display
together in Figure 22 & 23, showing trends of an increase (>1.1 fold), a decrease (<0.9), or no
change (between 1.1 and 0.9).
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APPENDIX IV
TISSUE SPECIFIC FOLD CHANGE FOR FIGURES 24-25

Fold increase or decrease in expression comparing Human vs. Mouse Fold Changes. Fold
change was calculated for each species based on their respective controls. These calculated folds
were used to define which graphs to display together in Figure 24 & 25, showing trends of an
increase (>1.1 fold), a decrease (<0.9), or no change (between 1.1 and 0.9).
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APPENDIX V
NUMBER OF FOCI PER CELL
Appendix Table 1. Number of Foci/cell in Epithelial Cells within OTC Over Time
0
1
2
3
4
5
6
7
8
2

0

836

39

1

3

0.1

461

58

25

10

4

1

506
117

139

154

112

66

37

16

7

3

0
0.1

479

30

6

1

2

361

67

45

36

28

8

5

2

1

0

236

0.1

267

7

1

2

226

32

16

2
24

72

3

1
15

7

2

Appendix Table 2. Number of Foci/cell in Fibroblast Cells with OTC Over Time
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